col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


652 Results       Page 1

 [1] 
Elsevier: Value in Health
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―02 Cost-effectiveness of oral nirmatrelvir/ritonavir in patients at high risk for progression to severe COVID-19 in the United States Josh Carlson, Volker Foos, Adam Kasle, Tendai Mugwagwa, Florin Draica, Timothy Lee Wiemken, et al. (+4)
2 [GO] 2023―Nov―01 A scoping review & taxonomy of epidemiological-macroeconomic models of COVID-19 Gabrielle Bonnet, Carl A.B. Pearson, Sergio Torres-Rueda, Francis Ruiz, Jo Lines, Mark Jit, et al. (+2)
3 [GO] 2023―Jun―10 OP17 Pilot Study Evaluating the Trends in Utilization of Compounded Products Pre- and Post- COVID-19 Pandemic D. Seo, T.J. Mattingly
4 [GO] 2023―Jun―10 OP16 The Importance of Clinical Research Organizations (CRO) in Clinical Research and Impact of COVID-19 Pandemic M. Dehlinger-Kremer, H. Lüning, Yaşaroğulları Ş, D. Rolando, L. Mahi
5 [GO] 2023―Jun―10 HSD111 Prescription Opioid Use Among Cancer Patients before and after the Onset of COVID-19: Evidence from Real-World Data B. Zhou, M. Pathak, R. Rasu, U. Sambamoorthi
6 [GO] 2023―Jun―10 HSD103 Impact of COVID-19 on Delivery of Cancer Care: Real-World Insights from Community Oncology Research Evaluations (CORE) R. Manimaran, S. Bhardwaj, I. Manigault, G. Wright, E. Vissers
7 [GO] 2023―Jun―10 EPH262 Preventing COVID-19 Outbreaks Using Wastewater Surveillance at Long-Term Care Facilities: A Pilot Modelling Study J. Wen, M.Y. Li, X.L. Pang, B.E. Lee, A. Ohinmaa
8 [GO] 2023―Jun―10 EPH257 Public Health Impact of UK COVID-19 Booster Vaccination during Omicron Predominance D. Mendes, R. Chapman, E. Aruffo, P. Gal, J.L. Nguyen, E. Hamson, et al. (+3)
9 [GO] 2023―Jun―10 EPH252 Contributions and Challenges of Pharmacists during a Public Health Crisis Such As COVID-19 A. Barseghyan, L. Nazaryan, M.H. Simonyan
10 [GO] 2023―Jun―10 EPH221 Persons Diagnosed with COVID-19 in the Clinical Practice Research Datalink (CPRD) Primary Care Dataset: A Cohort Description K. Andersen, M. Reimbaeva, L.J. McGrath, D. Mendes, T. Mugwagwa, J.L. Nguyen, et al. (+4)
11 [GO] 2023―Jun―10 EPH219 Digital Contact Tracing for COVID-19: Overview of Existing Systems and Framework for Future Innovation C. Mack, K. Rough, C. Tai, G. Farkas, E. Wasserman
12 [GO] 2023―Jun―10 EPH218 Cardiac Manifestations Including Heart Failure and Myocardial Infarction Post COVID-19 Recovery: A Systematic Review and Meta-Analysis M.K. Siddiqui, M. Siroula, S. Mathur, J. Gupta, K. Choudhry
13 [GO] 2023―Jun―10 EPH207 Factors Associated with COVID-19 Infections and Deaths in the Gulf Cooperation Council (GCC) Countries: A Time Series Cross-Section Analysis M. Alam, F. Alkhowar, M Al-mansoori, S Al-mohannadi
14 [GO] 2023―Jun―10 EPH208 Impacts of COVID-19 on Career Choices in Health Professionals and Medical Students L. Doan
15 [GO] 2023―Jun―10 EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis Y. Fu, J. Zhao, P. Han, L. Yang, T. Ren, S. Zhan, L. Li
16 [GO] 2023―Jun―10 CO181 Clinical Characteristics of Patients with Sars-Cov-2 Omicron Variant and COVID-19 Vaccination with Clinical Outcome Findings in Shanghai, China: A Single Center, Retrospective, Observational Study D. Yang, J. Li, H. Weng, X. Lu, W. Yang, J. Qiang, et al. (+3)
17 [GO] 2023―Jun―10 SA12 Use of Living Systematic Reviews (LSRS) Beyond COVID-19 V. Patel, P. Dabirvaziri, J. Tran, M.E Richard, S. Grieve, D. Thakur
18 [GO] 2023―Jun―10 RWD156 The Impact of the Sars-Cov-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany S. Schilling, K. Strobel, L. Kellermann, S. Wischlen, S. Luciano, J. Stacey, et al. (+4)
19 [GO] 2023―Jun―10 RWD152 Real-World Evidence on the Use of Ecmo in Hospitalized COVID-19 Patients: Results from a Linked Closed and Open Claims Database in the US S. Kuranz, D. Neilson
20 [GO] 2023―Jun―10 RWD144 The Short Run and Long Run Behavioral Effects of COVID-19 Vaccination Enforcement I. Baser, N. Rodriguez, Y. Azmoudeh
21 [GO] 2023―Jun―10 RWD142 Prospective Monitoring of Patients with COVID-19 Vaccination for Outcomes of Hospitalization Using Electronic Medical Record Network K. Nikolli
22 [GO] 2023―Jun―10 RWD118 Long-Term Neurologic Sequelae Among Patients with Varying COVID-19 Severity: An Administrative Claims Database Analysis I. Dhangar, R. Ahlawat, P. Veeranki, A. Anderson, J.T McPheeters, K.P Singh
23 [GO] 2023―Jun―10 RWD82 To Study the Impact of Long COVID-19 in the US - A 9-Month Retrospective Study A. Roy, A. Gupta, A. Nayyar, S. Bhargava, V. Dawar, V. Verma, et al. (+4)
24 [GO] 2023―Jun―10 RWD81 Long-Term Metabolic Sequelae of COVID-19, By Severity Levels I. Dhangar, P. Veeranki, A. Anderson, J.T McPheeters, K.P Singh, R. Ahlawat
25 [GO] 2023―Jun―10 RWD70 Comprehensive Code List Associated with CDC-Defined High-Risk Underlying Medical Conditions Leading to Potential Progression to Severe COVID-19 Outcomes A. Scott, F. Draica, J. Atkinson, R. Chambers, M. Reimbaeva, R. Stanford, et al. (+2)
26 [GO] 2023―Jun―10 RWD46 Reclassification of COVID-19 Related ICD-10 Codes in Mexico: A Real-World Data Analysis of 1,937,360 Hospital Discharges from the Ministry of Health D. Rodriguez, M. Osorio, I.C. Garcia-Appendini, J. Larrosa
27 [GO] 2023―Jun―10 RWD26 Variation in Demographic Characteristics, Socioeconomic Status, Clinical Presentation and Selected Treatments in Mortality Among Patients with a Diagnosis of COVID-19 in the United States R. Wade, R. Doshi, D. Tian
28 [GO] 2023―Jun―10 PCR184 Impact of COVID-19 Symptoms on Patients' Health-Related Quality of Life V. Li, K. Finlayson, H. Costantino
29 [GO] 2023―Jun―10 PCR157 Sociopsychological Factors Related to Information Seeking during the COVID-19 Pandemic T. Park, J. Muzumdar
30 [GO] 2023―Jun―10 PCR144 Evaluation of the Association between Self-Perceptions of Aging and Care Deferrals Among US Adults Aged ≥50 Years during the COVID-19 Pandemic S. Korgaonkar, P. Prajapati, M. Barnard, S. Goswami
31 [GO] 2023―Jun―10 PCR99 Regular COVID-19 Booster Shot Preference and Willingness to Pay in the Vietnamese Population: A Theory-Driven Discrete Choice Experiment B. Tran, Le Vu M, L. Doan
32 [GO] 2023―Jun―10 PCR62 Post-Lockdown Behaviors and Impacts of Avoiding COVID-19 in Individuals and Caregivers of Individuals at High-Risk of Severe COVID-19: A Qualitative Study T. Maia, R. Yokota, S. Arnetorp, J. Spiler, G. Settergren, P. Williams
33 [GO] 2023―Jun―10 PCR12 Delayed Care Among Low-Income Adults during the COVID-19 Pandemic: A US Population-Based Study J. Han
34 [GO] 2023―Jun―10 MT27 Comparison of High-Flow Nasal Canula and Non-Invasive Mechanical Ventilation in Treating COVID-19 Patients Q. Gu, Y. Dai, A. Harvey
35 [GO] 2023―Jun―10 MT3 Delphi Panel on the Recommended Use of the Cue COVID-19 at Home Diagnostic Test D. Tsay, L. Pastor, S. Whitney, M. Bourque, N. Duggal
36 [GO] 2023―Jun―10 HSD99 Telemedicine and the Utilization of Outpatient Mental Health Services By Patients with Incident Major Depressive Disorder during the COVID-19 Pandemic S. Axeen, S. Jin, O. Lubarsky, B. Kenou, R. Chapman, R. Xie, S. Seabury
37 [GO] 2023―Jun―10 HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting F. Devine, A. Clary, J.H. Liu, Y.C. Wu, J. Park, A. Bhat
38 [GO] 2023―Jun―10 HSD73 Characteristics of Type 2 Diabetes Patients That Used Virtual Care Since COVID-19 Pandemic: Evidence from a Large Commercial Healthcare Claims Database in the US H. Ahn, V. Thao, B. Borah
39 [GO] 2023―Jun―10 HSD58 Impact of the COVID-19 Pandemic on Cervical Cancer Screening Rates in Colombia: An Interrupted Time Series Analysis, Stratified By Region R. Thomas, D. Guarin
40 [GO] 2023―Jun―10 HSD51 Differences in Disease Burden and Treatment Utilization By Socioeconomic Status Among a Large Cohort of Patients with COVID-19 Diagnosis in the United States R. Wade, D. Tian, R. Doshi
41 [GO] 2023―Jun―10 HSD25 Study of Pharmacists' Awareness Regarding Coronavirus Disease (COVID-19) in Ukraine O. Zaliska, O. Semenov, Z. Zabolotnya, N. Maksymovych
42 [GO] 2023―Jun―10 HSD16 Impact of Provider Nudges on Herpes Zoster Vaccine Series Completion during the COVID-19 Pandemic in the United States J. Gatwood, A. Brookhart, O. Kinney, T.M. Hagemann, C.Y. Chiu, S. Ramachandran, et al. (+2)
43 [GO] 2023―Jun―10 HSD18 Patient Experience of Using Telehealth Services during COVID-19 in Dubai Health Authority: A Retrospective Cross-Sectional Electronic Survey W. Alnakhi, N. Alzarouni
44 [GO] 2023―Jun―10 HSD9 Impact of Participation in Colorectal Cancer Screening during the COVID-19 Pandemic in Japan C. Hamashima, H. Sano
45 [GO] 2023―Jun―10 HPR89 Trends in Remote Patient Monitoring Among Medicare Beneficiaries during COVID-19: A Comparative Interrupted Time Series Analysis R. Mahashabde, A. Pandit, M. Acharya, M.M. Ali, C. Bogulski, H. Eswaran, C. Hayes
46 [GO] 2023―Jun―10 EPH205 A Global Analysis of COVID-19 Infection Fatality Rate and Its Associated Factors during the Delta and Omicron Variant Periods Nhi N Thi Hong
47 [GO] 2023―Jun―10 EPH203 Patients Characteristics, Vaccine Uptake, Healthcare Resource Utilization and Costs Associated with Acute COVID-19 during the Omicron Predominant Period in Brazil: A Nationwide Database Study J. Yang, G. Cordeiro, M. Longato, M.H. Kyaw, A. Dantas, T. Senna, et al. (+2)
48 [GO] 2023―Jun―10 EPH204 COVID-19 Vaccination during Pregnancy: A Structured Electronic Medical Record Data Study B. Levy, C.D. Mullins, S. Haider, A. Elfman, G. Poorman, G.R. Saade
49 [GO] 2023―Jun―10 EPH198 The Sustained Impact of COVID-19 on Opioid Dispensing in California J. Zheng, C. Rakovski, T. Varisco, H. Chen, M. Fleming, Y. Wang
50 [GO] 2023―Jun―10 EPH189 Assessment of Burden of COVID-19 Infection and the Dynamics in African Union Member States O. Mgbere, O.C. Nwabuko, O. Olateju, O. Adepoju, W. Liaw, C. Darkoh, E.J. Essien
51 [GO] 2023―Jun―10 EPH174 Trends in Postpartum Depression before and during the COVID-19 Pandemic and Correlates of Treatment Choices: A Population-Based Retrospective Cohort Study D. Do, T. Lee, U. Patel
52 [GO] 2023―Jun―10 EPH169 Persons Diagnosed with COVID-19 in Linked Clinical Practice Research Datalink (CPRD) - Hospital Episode Statistics (HES) Data: A Cohort Description K. Andersen, M. Reimbaeva, L.J. McGrath, D. Mendes, T. Mugwagwa, J.L. Nguyen, et al. (+4)
53 [GO] 2023―Jun―10 EPH166 The Effect of COVID-19 on Maternal and Neonatal Outcomes in a Large Tertiary Health System in Saudi Arabia A. Almutairi, N. Al-Fadel, M Al Ammari, N. Al Makhlafi, S. Al Mahmoud, M Al Shammari, et al. (+2)
54 [GO] 2023―Jun―10 EPH168 Regional Variation in Patient Characteristics and Treatment Patterns for over 17 Million COVID-19 Patients in the United States R. Doshi, D. Tian, R. Wade
55 [GO] 2023―Jun―10 EPH155 Relative Effectiveness of Vaccination and Non-Pharmaceutical Interventions on COVID-19 Infection and Deaths in the US A.P. Khatiwada, A.G. Gebremariam, M. Genie, T.C. Lai, N. Poudel, S. Ngorsuraches
56 [GO] 2023―Jun―10 EPH113 Healthcare Utilization Remains Elevated Among People Living with Post-COVID-19 Condition More Than One Year after Acute COVID-19 Illness M. Binka, B. Klaver, G. Cua, B. Sander, H. Sbihi, N.Z. Janjua
57 [GO] 2023―Jun―10 EPH99 Janssen COVID-19 Vaccine Safety in a Real-World Setting: A Pharmacovigilance Study A. Braga, Q.C. Morais, M. Da Costa, M. Santos
58 [GO] 2023―Jun―10 EPH98 Cutaneous Adverse Drug Reactions of COVID-19 Vaccines: A Cross-Sectional Study of the Largest Healthcare System in Taiwan S.L. Tan, Y.H. Chen, H.Y. Chen, S.C. Shao
59 [GO] 2023―Jun―10 EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai D. Yang, H. Weng, Y. Song, J. Li, X. Lu, W. Yang, et al. (+4)
60 [GO] 2023―Jun―10 EPH97 Application of Self-Protective Behaviors in Balancing Objective and Subjective COVID-19 Risk Assessments Among Residents in an Urban Setting O. Mgbere, S. Iloanusi, I. Yunusa, N.J.R. Iloanusi, S. Gohil, E.J. Essien
61 [GO] 2023―Jun―10 EPH85 A Cross- Sectional Assessment of Impact of COVID-19 Vaccine on Menstrual Cycle of Pharmacy and Medical Students of Qassim University, Saudi Arabia K. Alrobaian, M. Farooqi, G. Alwanin, R. Alzain, S. Almutairi, M. Alsaeed
62 [GO] 2023―Jun―10 EPH65 The Analysis of Dynamic Processes of Virus Transmission: How Could Diagnostic Tests and Vaccinations Can Stop COVID-19 Pandemic? I. Kamae
63 [GO] 2023―Jun―10 EPH61 Uptake of the Post COVID-19 Condition ICD-10-CM Diagnosis Code By Social Factors A.D. Lee, C. Prener, A. Scott, T. Alfred, D. Oliveri, D. Malhotra, L.J. McGrath
64 [GO] 2023―Jun―10 EPH50 Impact of COVID-19 on the Change in Work Conditions and Career Choices in General Vietnamese Population L. Doan, VA Trong Dam, H.T. Nguyen, T.T. Nguyen
65 [GO] 2023―Jun―10 EPH47 Active Surveillance for Safety Monitoring of COVID-19 Vaccines in Saudi Arabia S. Alhabardi, L. Alhusayni, M. Aljebreen, A. Alzamil, M. AlSwead, M. Alrohaimi, F. Al-Harbi
66 [GO] 2023―Jun―10 EPH44 On the Frontline Against COVID-19: Provision of Community Pharmacy Services during a Public Health Crises L. Nazaryan, A. Barseghyan, M.H. Simonyan
67 [GO] 2023―Jun―10 EPH26 Barriers to in-Person Focus Group Participation during the Third-Year of COVID-19 Pandemic: A Case Study of Colorectal Cancer (CRC) Screening in Underrepresented Groups R. Rasu, L.A. Miller-Wilson, S. Kamt, A. White, S. Chhetri, R. Hittson-Smith, et al. (+2)
68 [GO] 2023―Jun―10 EPH9 Characterization of Demographics and Concomittant Symptoms in Patients with Post COVID-19 Conditions or Long COVID S. Srinivasan, J. Morgan
69 [GO] 2023―Jun―10 EE335 A Multicenter Microcosting Study for COVID-19 in Brazil R. Bertoglio Cardoso, M. Marcolino, M.S. Marcolino, L. Moreira, F. Anschau, L. Kopittke, et al. (+5)
70 [GO] 2023―Jun―10 EE333 Assessment of Medically-Attended COVID-19 Patient Risk Profiles and Health Care Resource Utilization (HCRU) and Costs in the U.S. M. Chacon-Araya, J. Tkacz, M. Zagari, T. Bello, B. Lewing, S. Brusky
71 [GO] 2023―Jun―10 EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom M. Kohli, M. Maschio, A. Lee, S. Carroll, N. Van de Velde, M. Drummond
72 [GO] 2023―Jun―10 EE326 Malnutrition Prevalence and Economic Burden Among US Hospitalized Older Adult Patients with and without COVID-19 T. Zhang, S. Sulo, S. Drawert
73 [GO] 2023―Jun―10 EE319 Healthcare Resource Utilization and Direct Medical Costs Associated with Post COVID-19 Condition in Colombia, 2020-2021 F. Salcedo Mejía, N.J. Alvis Zakzuk, A. Lozano, L. Moyano, N.R. Alvis Zakzuk, J.C. Fernandez Mercado, et al. (+4)
74 [GO] 2023―Jun―10 EE299 Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial S. Prada, M.P. Garcia-Garcia, G.A. Ospina-Tascón, D. Rosselli
75 [GO] 2023―Jun―10 EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission M. Chacon-Araya, J.D. Ortendahl, J. Lee, M. Broder, S. Brusky
76 [GO] 2023―Jun―10 EE229 The Effect of COVID-19 on Care for Chronic Wounds Among Medicare Beneficiaries Using Medicare Claims - 2019, 2020, and 2021 M. Carter, J. DaVanzo, R. Haught, M. Nusgart, D. Cartwright, C. Fife
77 [GO] 2023―Jun―10 EE213 Long COVID-19 Associated with 5-Fold Increase in Total Medical Costs and Greater Use of Inpatient and Outpatient Services Compared to Non-Long COVID-19: An Analysis of Real-World Data M. Chacon-Araya, J. Tkacz, M. Zagari, T. Bello, B. Lewing, S. Brusky
78 [GO] 2023―Jun―10 EE122 The Economic Impact of a Psychosocial Utility Benefit Associated with Pre-Exposure Prophylaxis (PrEP) for COVID-19, in Immunocompromised (IC) Individuals - a Case Study for Future PrEP Evaluations T. Henry, M. Fisher, T. Holland, M. Watt, S. Arnetorp, A. Jańska, D. Squirrell
79 [GO] 2023―Jun―10 EE123 Cost Evaluation of COVID-19 Remote Home Monitoring Services' Patients in England during Wave 2 from October 2020-April 2021 S. Tomini
80 [GO] 2023―Jun―10 EE98 Health Economic Evaluation of COVID-19 Vaccines: A Systematic Literature Review Y. Li, I. Guerra, K. Rtveladze, J. Leite, M. Vandoulakis, L. Eggendorfer, M. D'Alessandro
81 [GO] 2023―Jun―10 EE21 COVID-19 Premature Mortality Productivity Losses: Real World Information Analysis E. Tanaka, G.K. Tanaka, R. Kuabara, E.M. Massuda, L. Assunção-Costa, C. Tafla, et al. (+2)
82 [GO] 2023―Jun―10 CO149 Prevalence of Chain-of-Event and Contributing Conditions Among Treated COVID-19 Patients in the United States: Identifying Risk Factors Associated with Deaths R. Doshi, D. Tian, R. Wade
83 [GO] 2023―Jun―10 CO142 Evaluating the Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Outcomes in the Stroke Belt E. Stitzlein, F. Pathan, I. Weimer, K. Lodaya, F. D'Souza, A. Shenoy
84 [GO] 2023―Jun―10 CO134 The Future of COVID-19: What Is Next in the Drug Pipeline A. Carey
85 [GO] 2023―Jun―10 CO130 Dyspnea and Health-Related Quality of Life in Patients with Persistent Symptoms after at Least Six Months of Hospital Discharge Due to COVID-19 A. Lozano, F. Salcedo Mejía, N.R. Alvis Zakzuk, L. Moyano, M. Jerez Arias, J. Paz Wilches, et al. (+4)
86 [GO] 2023―Jun―10 CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) C. Bell, P. Bobbili, R. Desai, D. Gibbons, V. Patel, M. DerSarkissian, et al. (+5)
87 [GO] 2023―Jun―10 CO56 Real-World Effectiveness of Early Treatments for COVID-19: Evidence from Administrative Claims Data C. Bell, T. Lokhandwala, D. Gibbons, V. Patel, M. Drysdale, J. Wang, E. Lloyd
88 [GO] 2023―Jun―10 CO14 Disparities in COVID-19 Related Outcomes in the United States By Race and Ethnicity: An Umbrella Review of Meta-Analyses K. Duong, L. Le, S.K. Veettil, P. Saidoung, W. Wannaadisai, R.E. Nelson, et al. (+7)
89 [GO] 2023―Jun―10 P55 Budget Impact Analysis of COVID-19 Vaccines on U.S. Medicare and Commercial Health Plans after Depletion of the Federally-Purchased Supply H. Vu, K. Nguyen, J. Hendricks
90 [GO] 2023―Jun―10 P11 Depression Severity Among Patients with Psychiatric Disorders during the COVID-19 Pandemic E. Yung, J. Yin, J. Park, U. Periyanayagam
91 [GO] 2023―Jun―10 P10 The Public's COVID-19 Fatigue and Mental Health Towards COVID-19 Public Health and Social Measures (PHSMS) and Mental Health in China: A Discrete Choice Experiment T. Liu, Z. He, W.K. Ming
92 [GO] 2023―Jun―10 EPH66 Epidemiological Population Study of Sars-Cov-2 in Lake County, Illinois: Contact: Health-Related Quality of Life Assessment O. Sanchez-Solino, R.D. Kilpatrick, C. Johnson, Y. Fang, K. Zarish, Y. Ye, et al. (+2)
93 [GO] 2023―Jun―10 CO105 The Association of Sars-Cov-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review N. Vadlamudi, C.A. Basham, J.C. Johnston, F.A. Khan, G.B. Migliori, R. Centis, et al. (+5)
94 [GO] 2023―Jun―10 CO93 A Qualitative Investigation of the Impact of the Sars-Cov-2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting S. Nesto, J. Stanley, S.E. Howlett, C.A. Chapman
95 [GO] 2023―Jun―10 HPR47 Access to Prenatal Care and Poverty in Colombian Regions: Before and in the Pandemic N. Alvis-Guzman, F. De La Hoz
96 [GO] 2023―Jun―10 EE14 Cost-Effectiveness of Non-Pharmaceutical Interventions (NPI), Vaccines and the Combination of NPI and Vaccines in Managing the COVID Pandemic J. Lou, C.G.X. Cai, H. Clapham, Y. Teerawattananon, H.L. Wee
97 [GO] 2023―Jun―10 EPH62 Annual Burden of Non-COVID-19 Respiratory Tract Infections in the Pre- to Post- Pandemic Eras: Analysis from the Anlitiks’ All Payor Claims Database K. Rajagopalan, A. Grossman, E. Zwick
98 [GO] 2023―Jun―10 EPH109 Excess Mortality from Diabetes Mellitus in the First Year of the Pandemic in Colombia N. Alvis-Guzman, N.J. Alvis Zakzuk, F. De La Hoz
99 [GO] 2023―Jun―10 HSD10 Efficiency of the Cervical Cancer Program on the Budget Execution Processes during COVID 19 Pandemic Years 2020 - 2021 in Peru FM Perez Garcia, A. Gutierrez-Aguado, D. Guarin
100 [GO] 2023―Jun―10 EPH49 Did Gender Healthcare Disparity Against Women Exist in Chile during the First Two Years of the Pandemic? S. Arenillas, A. Rada, S. Avila, C. Valdes
101 [GO] 2022―Dec―14 EPH69 Health Inequity in Viral Infections in a Medicaid Population: Lessons From Influenza and COVID-19 B Brady, LA Palmer
102 [GO] 2022―Dec―14 HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19 S Warttig, C Ling
103 [GO] 2022―Dec―14 EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 J Seinfeld, A Sobrevilla, ML Rosales, M Ibañez, C Munayco, S Londono
104 [GO] 2022―Dec―14 HTA257 MOVe-OUT: A Trial of Two Halves - The Impact of Heterogeneity on Cost-Effectiveness Outcomes for COVID-19 D McConnell, L Mccullagh, C Usher, C Walsh, M Barry, R Adams
105 [GO] 2022―Dec―14 PCR46 Assessing the Mental Health of Secondary School Students in the Light of COVID-19 R Vajda, E Karamán, T Csákvári, K Fusz, H Khatatbeh, E Miszory, et al. (+2)
106 [GO] 2022―Dec―14 RWD68 Characteristics/Comorbidities of Vaccinated and Unvaccinated Patients With COVID-19 A Roy, R Markan, S Kumar, V Verma, I Kukreja, A Gaur, et al. (+6)
107 [GO] 2022―Dec―14 PCR168 The Changing Face of Qualitative Interviewing in Clinical Outcome Assessments Research: Conducting Qualitative Interviews Post COVID-19 J Randall, S Keith, J Clegg
108 [GO] 2022―Dec―14 CO50 Efficacy and Safety of Itolizumab for the Treatment of Coronavirus Disease (COVID-19): A Systematic Literature Review NS Gurram, RB Vagicharla, G Rayapureddy, P Kummari, K Pulleddula, J Mir, et al. (+6)
109 [GO] 2022―Dec―14 CO178 Cardiovascular, Neurological, and Ocular Complications of COVID-19 Among Indian Patients - A Targeted Literature Review A Krishna, A Vhanakalas, MK Rai, R Gautam
110 [GO] 2022―Dec―14 HSD18 Access to Healthcare Services During COVID-19 Restrictions in Kazakhstan: A Nationwide Survey on COVID-19 and Lifestyle Changes B Iskakova, B Zhussupov, A Izekenova, A Izekenova, A Myrkassymova, A Bukharbayeva, et al. (+4)
111 [GO] 2022―Dec―14 EE110 Psychological Impact of COVID-19 and the Economic Burden of Rheumatic and Musculoskeletal Diseases V Lorenzoni, I Palla, G Andreozzi, G Fulvio, C Tani, F Trentin, et al. (+4)
112 [GO] 2022―Dec―14 HPR63 Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines E Bell, S Brassel, H Schirrmacher, E Oliver, S Arnetorp, K Berg, et al. (+6)
113 [GO] 2022―Dec―14 HTA161 A Systematic Review of the Safety of COVID-19 Anti-Interleukin Therapy J Gomon, A Kolbin, FM Sultanova, Y Balykina
114 [GO] 2022―Dec―14 MSR32 COVID-19 Beds’ Occupancy and Hospital Complaints: A Predictive Model E Foglia, LB Ferrario, D Bellavia, F Schettini, E Falletti, C Gallese, et al. (+2)
115 [GO] 2022―Dec―14 EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany A Müller, B Ultsch, A Nasir, T Certejan, P Buck, A Ben, et al. (+3)
116 [GO] 2022―Dec―14 EE540 Cost-Effectiveness of Vaccines Targeting Infectious Diseases - Has COVID-19 Changed the Landscape? R Pitman, P Khurana
117 [GO] 2022―Dec―14 RWD111 Influenza Vaccine Sales During the COVID-19 Era A Ngami, T Christie, F Guelfucci, F Bianic, P Net
118 [GO] 2022―Dec―14 SA43 Rapid Evidence Publication in the COVID-19 Era: Impact on Study Quality and Study Identification C Wright, K Misso, R Green, Z Marjenberg
119 [GO] 2022―Dec―14 HPR43 Differences in Inequalities of Uterine Cancer Treatment Before and After COVID-19 in England H Brewer, CT Rice, C Winton, S Jarvis, M Hamlyn, J Davidson
120 [GO] 2022―Dec―14 EPH4 Burden and Characteristics of COVID-19 in France During 2020 Based on National Hospital Database C Leboucher, C Blein, V Machuron, K Le Lay, K Benyounes, A Millier, F Raffi
121 [GO] 2022―Dec―14 EPH64 Public Health Impact of COVID-19 in French Ambulatory Patients With at Least One Risk Factor for Severe Disease R Supiot, A Millier, K Benyounes, V Machuron, K Le Lay, M Sivignon, et al. (+3)
122 [GO] 2022―Dec―14 EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece K Athanasakis, N Nomikos, C Tsoulas, K Zisis
123 [GO] 2022―Dec―14 HTA17 Cost-Effectiveness Analysis of Tocilizumab for The Treatment of COVID-19 in Hospitalised Patients on Corticosteroids, From the Italian NHS Perspective N Jovanoski, A Dario
124 [GO] 2022―Dec―14 EPH7 A Survey of the Occurrence and Transmission of COVID-19 in Outdoor Education Settings in Canada S Szabo, S Walker, T Edgar, J Kretnzel, K Johnston, B Stone
125 [GO] 2022―Dec―14 EE465 Cost-Effectiveness of Sotrovimab for the Treatment of Mild-to-Moderate COVID-19 in Patients at High Risk of Disease Progression in Italy F Piccolo, J Tosh, S De Boisvilliers, S Patel, V Patel
126 [GO] 2022―Dec―14 EE572 Cost-Effectiveness of AZD7442 (Tixagevimab and Cilgavimab) for Pre-exposure Prophylaxis Against COVID-19 in the Immunocompromised Population K Sutton, P Miller, N Branscombe, M Mittal, C Browne, S Arnetorp, et al. (+5)
127 [GO] 2022―Dec―14 RWD129 A Comparison of ICU Admission Rate and Related Cost Among Patients Taking Nirmatrelvir and Ritonavir Combination Versus Molnupiravir for Treatment of Mild to Moderate COVID-19 in the US I Kukreja, A Gaur, N Upadhyay, S Bhalani, A Gupta, V Verma, et al. (+6)
128 [GO] 2022―Dec―14 CO43 The Role of Different Biomarkers in the Prognosis of COVID-19 Infection B Horváthné Galántai, Z Ujszászi, S Tímea, K Takács, I Boncz, B Varga, et al. (+2)
129 [GO] 2022―Dec―14 RWD98 Variation in COVID-19 Length of Stay Due to Social Factors in the US - Estimation Using Integration of CDC/ATSDR's Social Vulnerability Index (SVI) and Healthcare Claims Data A Nayyar, U Raj, M Rastogi, S Daral, V Verma, A Gaur, et al. (+6)
130 [GO] 2022―Dec―14 P67 Cumulative Effect of Depression on Health Worsening During The COVID-19 Lockdown Among Diabetic Patients in Europe T Laurent, L Bonnal, P Favard
131 [GO] 2022―Dec―14 PCR257 Humanistic Burden Pre and Post COVID-19 on Caregivers of Cancer Patients in Japan and China: A NHWS Survey WH Tan, A Grillo, Y Chen, A Woo
132 [GO] 2022―Dec―14 RWD57 Epidemiological Study of the Burden of COVID-19 on Depression in Men (DIM) in Pre- and During COVID-19 Pandemic Using Real-World Data A Sharma, V Verma, S Pandey, A Nayyar, S Daral, I Kukreja, et al. (+6)
133 [GO] 2022―Dec―14 RWD60 Exploring the Burden of COVID-19 on Eating Disorders Spectrum (Types of Eating Disorders) in Pre- and During-COVID-19 Pandemic Using Real-World Data V Verma, N Verma, A Gaur, K Paul, A Chopra, S Daral, et al. (+7)
134 [GO] 2022―Dec―14 HSD93 Investigating the Impact of COVID-19 on Haemodialysis CT Rice, GA Unal, S João Carvalho, J Davidson
135 [GO] 2022―Dec―14 P65 Impact of COVID-19 on Hospital Screening, Diagnosis and Treatment Activities Among Prostate and Colorectal Cancer Patients in Canada FSH Lee, M Halat, N Bleibdrey, S Zhang, R Chalmers, D Zimskind
136 [GO] 2022―Dec―14 PCR150 Physicians’ Perceptions of the Impact of COVID-19 on Patient Access and Adherence J Cook, S Donde, K Gilchrist, M Pittaoulis, M Sapia
137 [GO] 2022―Dec―14 RWD128 Exploring the Burden of COVID-19 on Post-Traumatic Stress Disorder (PTSD) in Pre- and During-COVID-19 Pandemic Using Real-World Data I Kukreja, A Sharma, V Verma, A Nayyar, S Daral, A Gaur, et al. (+7)
138 [GO] 2022―Dec―14 RWD95 Exploring the Burden of COVID-19 on Suicides and Suicidal Attempts (SSA) in Pre- and During-COVID-19 Pandemic Using Real-World Data A Gaur, K Paul, A Sharma, V Verma, A Chopra, A Roy, et al. (+4)
139 [GO] 2022―Dec―14 EPH91 Association Between Mental Disorders and COVID-19 Outcomes in Hospitalized Patients in France: A Retrospective Nationwide Population-Based Study A Descamps, J Frenkiel, K Zarca, C Laïdi, O Godin, O Launay, et al. (+2)
140 [GO] 2022―Dec―14 PCR221 Health-Related Quality of Life Among Working Nurses in Hong Kong: The Role of Resilience Under the COVID-19 Pandemic E Wong, AWL Cheung, AYK Wong, JCH Ma, TKS Sun, CHK Yam, et al. (+3)
141 [GO] 2022―Dec―14 HSD99 Analysis of the Balanced Scorecard's Customer Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
142 [GO] 2022―Dec―14 HSD76 Analysis of the Balanced Scorecard's External Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
143 [GO] 2022―Dec―14 HSD53 Analysis of the Balanced Scorecard's Internal Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
144 [GO] 2022―Dec―14 HSD30 Analysis of the Balanced Scorecard's Financial Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
145 [GO] 2022―Dec―14 HSD31 Analysis of the Balanced Scorecard's Managerial Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
146 [GO] 2022―Dec―14 HSD7 Analysis of the Balanced Scorecard's Knowledge and Growth Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
147 [GO] 2022―Dec―14 EPH180 Acute Coronary Heart Syndrom (ACS): Hospitalizations in Germany Before and During COVID-19 Pandemic S Wahler, A Ben, A Müller
148 [GO] 2022―Dec―14 EPH171 Delivery Outcomes in the United States Among Women With Commercial or Medicaid Insurance During the COVID-19 Pandemic B Brady, E Packnett, LA Palmer
149 [GO] 2022―Dec―14 EPH67 Sleep Disorders, Depression, Anxiety, and Stress During the COVID-19 Pandemic L Kovács, I Boncz, T Csákvári, Z Kívés
150 [GO] 2022―Dec―14 EPH66 Underground Economy - A Parameter of Social Influence During the COVID-19 Pandemic I Yfantopoulos, A Efstathiou, G Stefanakos, I Kehris, P Efstathiou, F Zora
151 [GO] 2022―Dec―14 EE610 Economic Investment for Saving a Year of Life Following the Israeli Government's Actions in the First Year of the COVID-19 Pandemic N Khoury Nakhoul, S Brammli-Greenberg
152 [GO] 2022―Dec―14 EE267 Evolution of Country Gross Domestic Product Following the COVID-19 Pandemic A Ngami, P Net
153 [GO] 2022―Dec―14 CO153 Mind-Body Modalities for Healthcare Workers in the COVID-19 Pandemic CY Kwon, B Lee
154 [GO] 2022―Dec―14 SA14 Clinical Evidence on Corticosteroid Treatment Reported in the First Year of the COVID-19 Pandemic - Comparison of Clinical Trial Publications and Treatment Recommendation S Wüstner, S Hogger, D Gartner-Freyer, A Friederich, K Schley, F Leverkus
155 [GO] 2022―Dec―14 HPR205 Future-Proofing European Regulatory and Market Access Practices Based on Learnings From the COVID-19 Pandemic - Stakeholder Perspectives Z Claessens, G Beirne, C Decouttere, N Vandaele, I Huys, L Barbier
156 [GO] 2022―Dec―14 EPH157 Physical Activity Level in Association with Mental Health Before and During the Restrictions of the First Three Waves of COVID-19 Pandemic Among Hungarian Adults P Ács, I Boncz, B Molics, V Prémusz, D Paár, K Morvay-Sey, et al. (+3)
157 [GO] 2022―Dec―14 HTA250 Health Technology Assessment Policy and Guideline Changes in the EU-5 During the COVID-19 Pandemic Era: An Insight Into Trends and Drivers S Ghosh, M Chatterjee
158 [GO] 2022―Dec―14 HPR118 An Updated Estimate of the Direct Cost of the COVID-19 Pandemic for the Greek Healthcare System K Athanasakis, N Nomikos, I Kyriopoulos, K Souliotis
159 [GO] 2022―Dec―14 EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus R Zambrano, M Cabezas, G Loor, N Aguirre, C Miño
160 [GO] 2022―Dec―14 HSD49 Improving Influenza Vaccination Rates: Evaluation of Pharmacy Vaccination Model Project During COVID-19 Pandemic in Germany U May, C Bauer, C Giulini-Limbach, TK Pham, A Schneider-Ziebe
161 [GO] 2022―Dec―14 SA54 Physical and Mental Health Among Frontline Healthcare Workers During COVID-19 Pandemic in Hungary K Kósa, I Boncz, B Molics, P Tardi
162 [GO] 2022―Dec―14 HTA65 Socio-Economic Determinants of Health Status During COVID-19 Pandemic in Hungary FF Xu, V Brodszky
163 [GO] 2022―Dec―14 HPR37 Comparing Reimbursement of New Drugs During the COVID-19 Pandemic in Ireland and Scotland D McLoughlin, B Dooley, C Copeland
164 [GO] 2022―Dec―14 PCR23 Humanistic Burden and Mental Conditions Among Cancer Patients Before and During the COVID-19 Pandemic in Japan and China WH Tan, Y Chen, M Gao, A Woo
165 [GO] 2022―Dec―14 RWD142 General Vaccine Dispensing Patterns During the First Year of the COVID-19 Pandemic in South Africa I Truter
166 [GO] 2022―Dec―14 RWD130 The Effect of the COVID-19 Pandemic in the Prevalence of Diabetes Mellitus Type 1 and 2 in Children and Young Adults in Greece: Real World Data from Greece L Daflla, K-A Poulia, J Doupis, N Kotsopoulos, I Yfantopoulos
167 [GO] 2022―Dec―14 EPH5 Impact of the COVID-19 Pandemic on Cervical and Breast Cancer Screening B Brady, LA Palmer
168 [GO] 2022―Dec―14 SA13 The Impact of the COVID-19 Pandemic on Collaboration and Innovation in Antiviral Drug Development: A Multi-Stakeholder Systems Dynamics Analysis G Beirne, C Decouttere, N Vandaele, C Van Riet, L Boey, Z Claessens, et al. (+2)
169 [GO] 2022―Dec―14 RWD139 Impact of the COVID-19 Pandemic on Diagnosis and Cancer-Related Medical Procedures in Brazil JP Reis Neto, J Busch, S Stefani
170 [GO] 2022―Dec―14 PCR131 Resilience, and Positive Parenting in Parents of Children With Autism and Intellectual Disability: Evidence From the Impacts of the COVID-19 Pandemic on Family's Quality of Life and Parent-Child Relationships C Bolbocean, K Rhidenour, M McCormack, B Suter, J Holder
171 [GO] 2022―Dec―14 EPH203 Estimating the Impact of COVID-19 Pandemic on Gynaecology Treatment in England R Sloan, E Morris, R Walworth, R King, A Marsland, BD Bray, J Pearson-Stuttard
172 [GO] 2022―Dec―14 SA62 Impact of the COVID-19 Pandemic on Health Care Resource Utilisation and Costs in Asthma in England: A Population-Based Study KJ Rothnie, T Tritton, X Han, T Holbrook, B Numbere, AF Ford, et al. (+8)
173 [GO] 2022―Dec―14 SA8 Impact of the COVID-19 Pandemic on Health Care Resource Utilisation and Costs in COPD in England: A Population-Based Study AS Ismaila, T Tritton, X Han, T Holbrook, B Numbere, AF Ford, et al. (+8)
174 [GO] 2022―Dec―14 HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe R Hutcheson, M Agrawal, S Singh, R Vishwakarma, A Chaupin
175 [GO] 2022―Dec―14 CO88 The Impact of COVID-19 Pandemic on Health-Related Quality of Life Outcomes: Evidence From a Longitudinal Study on Children With Rare Disorders C Bolbocean, J Holder
176 [GO] 2022―Dec―14 EPH114 Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery I Gountas, A Favre-Bulle, K Saxena, A Skroumpelos, U Sabale
177 [GO] 2022―Dec―14 EPH109 Impact of COVID-19 Pandemic on HPV Vaccine Initiation Rates in Adolescent Girls: Projected Time to Reverse Dose Deficits in France C Mamane, G Farge, L Bensimon, E Morais, K Saxena
178 [GO] 2022―Dec―14 EPH24 The Impact of COVID-19 Pandemic on Paediatric Vaccination Coverage Rates H Collings, A Karakusevic, R Newman
179 [GO] 2022―Dec―14 RWD82 Influence of the COVID-19 Pandemic on Patients Receiving Oral Anticoagulants for the Treatment of Non-Valvular Atrial Fibrillation J Comin-Colet, A Sicras-Mainar, I Pérez Román, J Salazar, MI del Campo Alonso, A Echeto, et al. (+2)
180 [GO] 2022―Dec―14 RWD164 The Impact of the COVID-19 Pandemic on Patients With Type 2 Diabetes in Greece: Results From a Real-World Study L- Daflla, K-A Poulia, J Doupis, N Kotsopoulos, I Yfantopoulos
181 [GO] 2022―Dec―14 HPR108 Impact of COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency: A Quantitative Assessment F Fiorentino, B Canali, L Candelora, T Halmos, P La Malfa, F Massara, et al. (+2)
182 [GO] 2022―Dec―14 EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis A Mevius, S Müller, T Wilke, U Maywald
183 [GO] 2022―Dec―14 EE391 Impact of the COVID-19 Pandemic on the Healthcare Resource Use of People With Newly Diagnosed Mood/Affective Disorder S Junker, R Knapp, P Hahn, U Maywald, F Hardtstock
184 [GO] 2022―Dec―14 EPH178 Impact Assessment of the COVID-19 Pandemic on Varicella Incidence Across Europe Using Digital Epidemiology Methods U Sabale, L Jarmale, J Murtagh, G Bencina
185 [GO] 2022―Dec―14 EPH14 Prevalence of Depression in Japan and the US Populations Before and During the COVID-19 Pandemic: A Retrospective Observational Study Using Real-World Data S Demiya, S Takeno, SW Kim, WS Lee, Y Sakai
186 [GO] 2022―Dec―14 EPH121 Future Trends of the COVID-19 Pandemics: What Should We Expect? H Leleu, M Blachier
187 [GO] 2022―Dec―14 RWD34 Comparison of ICU/Ventilator Usage Among Vaccinated and Unvaccinated COVID-19 Patients A Roy, A Gupta, M Rastogi, V Verma, I Kukreja, A Gaur, et al. (+7)
188 [GO] 2022―Dec―14 EE468 Healthcare Resource Utilisation and Costs Associated With the Management of Hospitalised COVID-19 Patients in England V Patel, S Beecroft, HJ Birch, D Gibbons, G Hall, D Heaton, et al. (+4)
189 [GO] 2022―Dec―14 EPH35 Post-COVID Conditions in Hospitalized COVID-19 Patients in Germany S Pacis, U Maywald, T Wilke, M Ghiani
190 [GO] 2022―Dec―14 EPH117 Coinfections in COVID-19 Patients in India: A Systematic Review K Khambholja, D Patel, V Chhaya, S Sekhar
191 [GO] 2022―Dec―14 PCR256 Humanistic Burden and Prevalence of Mental Conditions Among COVID-19 Patients in Japan and China WH Tan, Y Chen, HC Lin, V Grillo, A Woo
192 [GO] 2022―Dec―14 RWD101 Impact of COVID-19 Vaccination in Reducing Standard Hospitalization Cost Among COVID-19 Patients in the US - A Retrospective Study A Roy, A Gupta, M Rastogi, A Sharma, V Verma, I Kukreja, et al. (+7)
193 [GO] 2022―Dec―14 EE419 Economic Evaluation of Extracorporeal Membrane Oxygenation (ECMO) vs Invasive Ventilation for COVID-19 Patients with Severe Acute Respiratory Distress Syndrome (ARDS) K R.M., G Gopalan, K Kachroo, N Pudi, J Sharma
194 [GO] 2022―Dec―14 EE383 The Economic Burden of COVID-19 Prevention and Cases Management in Egypt from Governmental Perspective I Anan
195 [GO] 2022―Dec―14 P3 How Much Did the COVID-19 Shielding Policy Cost in Wales? Results of a Cost Analysis Within the EVITE Immunity Evaluation B. Sewell, A. Farr, A. Akbari, J. Morgan, V. Williams, A. Carson-Stevens, et al. (+6)
196 [GO] 2022―Dec―14 MT15 Obvio-19 App Ease of Use of Cancer Patients for Reporting COVID-19 Symptomology (ONCOVID Study) M Heidman, M Culbreth-Notaro, S Dallabrida, E Raymond, C Bartels
197 [GO] 2022―Dec―14 EPH99 Determinants of COVID-19 Vaccination in Hungary, Results of a Large Cross-Sectional Online Survey Z Beretzky, FF Xu, V Brodszky
198 [GO] 2022―Dec―14 EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States K Paret, H Beyhaghi, W Herring, M Rousculp, S Toback, J Mauskopf
199 [GO] 2022―Dec―14 EE632 Winning the COVID-19 Vaccine Race: How to Launch a Premium Priced COVID-19 Vaccine in a Competitive and Saturated Cost-Effectiveness Market R Folorunso, H Vyas, L Perez, M O'Brien
200 [GO] 2022―Dec―14 EPH53 The Role of Incentives- Parents’ Intention to Vaccinate Their 5- to 11-Year-Old Children with the COVID-19 Vaccine in Israel L Shmueli
201 [GO] 2022―Dec―14 RWD33 Analysis of COVID-19 Vaccine-Related Adverse Events in Adults, Geriatrics and Pediatrics - A Retrospective Study A Roy, H Khandelwal, A Gupta, M Rastogi, V Verma, S Pandey, et al. (+7)
202 [GO] 2022―Dec―14 P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 J. Mar, O. Ibarrondo, I. Larrañaga, M. Aguiar, N. Stollenverk, J. Bidaurrazaga, et al. (+2)
203 [GO] 2022―Dec―14 RWD67 Association of COVID-19 With Venous Thrombosis and Arterial Thrombosis S Pandey, R Markan, S Kumar, A Sharma, A Roy, V Verma, et al. (+5)
204 [GO] 2022―Dec―14 EPH106 Evaluating Changes in the Diagnostic Setting and Treatment of Bacterial Sexually Transmitted Infections in Germany During COVID-19: A Descriptive Analysis of German Claims Data From 2018-2021 RF Rios Chavarria, R Knapp, F Hardtstock, T Wilke, U Maywald
205 [GO] 2022―Dec―14 RWD161 Pharmacological Treatment Disruption in Women With Post-Partum Depression (PPD) During COVID-19: A Retrospective Cohort Study Using Claim Data K Paul, V Verma, A Sharma, A Roy, S Pandey, I Kukreja, et al. (+6)
206 [GO] 2022―Dec―14 EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon? A Ngami, T Christie, F Guelfucci, F Bianic, P Net
207 [GO] 2022―Dec―14 HPR86 Sustainability of Healthcare Systems in the Wake of COVID-19: The UK VPAS Case Study R Macaulay
208 [GO] 2022―Dec―14 SA59 Is There Life for Pre-Prints After COVID-19? P Wittkopf, R Raorane, C Casañas i Comabella, I Iheanacho
209 [GO] 2022―Dec―14 EPH153 Increased Prevalence of Post-Traumatic Stress Syndrome Among Healthcare Workers During the Coronavirus Epidemic P Bogdán, L Szabó, Z Verzár, H Khatatbeh, M Zrínyi, K Kozmann, et al. (+2)
210 [GO] 2022―Dec―14 HPR45 Medical Quality Indicators Trends During the Coronavirus Pandemic in Israel: Meuhedet Health Services Real Data Analysis and Future Conclusions S Klang, S Merling, S Regev-Rosenberg, M Pugatch
211 [GO] 2022―Dec―14 PCR272 Attitudes Towards Coronavirus Vaccination Among the Hungarian Population B Bernáth, L Szabó, M Zrínyi, R Ábrahám, G Kelemen, H Khatatbeh, et al. (+2)
212 [GO] 2022―Dec―14 PCR19 SARS-COV-1 Omicron BA.1 Associated Impact on Quality of Life and Medication Adherence of Multiple Myeloma Patients Treated With Thalidomide or Its Analogues Plus Dexamethasone 1JAN-31MAR2022 R Burruss, V Kim, V Arikian
213 [GO] 2022―Dec―14 EPH187 Effects of Non-Pharmaceutical Interventions (NPIS) Aimed at Limiting the Spread of SARS-COV-2 R Pentz, R Felder-Puig, I Soede, H Stürzlinger, L Teufl, R Winkler
214 [GO] 2022―Dec―14 EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance M Maschio, B Schweikert, B Ultsch, R Cai, K Fust, A Lee, et al. (+4)
215 [GO] 2022―Dec―14 HPR200 The Impact of Community Pharmacies on Regional Equity in Access to Professional Rapid Antigen Testing for SARS-COV-2 in Portugal J Guerreiro, I Teixeira, S Romano, J Mansinho, R Pereira, A Teixeira Rodrigues
216 [GO] 2022―Dec―14 PCR138 Association of SARS-CoV-2 Omicron Ba.1 on Adherence to Oral Tetrabenazine Congener and Quality of Life of Patients Diagnosed With Huntington's Disease With Chorea or Tardive Dyskinesia on the Service of a USA Specialty Pharmacy R Burruss, R Alhabashi, V Arikian
217 [GO] 2022―Dec―14 EPH68 Epidemiological Impact of Generalized SARS-COV-2 Vaccination of Children Aged 5 to 11 H Leleu, M Blachier
218 [GO] 2022―Dec―14 EPH150 The Psychological Impacts of COVID -19 as a Social Influence Parameter During the Pandemic I Yfantopoulos, A Efstathiou, G Stefanakos, I Kehris, P Efstathiou, F Zora
219 [GO] 2022―Dec―14 EE464 Is the Willingness to Pay for Years of Life in an Extreme Situation of the COVID Pandemic Closures Similar to the Willingness to Pay in Situations of Ordinary Basis? Comparison by Population Groups N Khoury Nakhoul, S Brammli-Greenberg
220 [GO] 2022―Dec―14 MSR141 Building Bridges: What Pandemic Preparedness Can Learn From Real-Option Value Analyses of Water Infrastructure in the Netherlands M Schöttler, S Van der Pol, S van der Schans, C Boersma
221 [GO] 2022―Dec―14 HPR30 Too Ultra-Rare for Care? Orphan Drug Availability for People Living With Ultra-Rare Respiratory Diseases in the Pre, Present and Post Pandemic Worlds H Matthews, N Lipunova, S Beecroft, G Jones
222 [GO] 2022―Dec―14 SA25 Evolution of the Number of Metastatic Lung Cancer Patients before and during the COVID 19 Pandemic: A French National Hospital Database Analysis B Sano, N Petrica, R Finas, M Rosé
223 [GO] 2022―Nov―25 Disability-Adjusted Life Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United States Qiushi Chen, Paul M. Griffin, Sarah S. Kawasaki
224 [GO] 2022―Oct―01 The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis Stacey Kowal, Carmen D. Ng, Robert Schuldt, Daniel Sheinson, Richard Cookson
225 [GO] 2022―Aug―11 Modeling the Recovery of Elective Waiting Lists Following COVID-19: Scenario Projections for England Nicholas C. Howlett, Richard M. Wood
226 [GO] 2022―Jul―20 Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: Correspondence Pathum Sookarodee, Viroj Wiwanitkit
227 [GO] 2022―Jun―25 PCR80 Informing a Conceptual Framework for a Patient-Centered Value Assessment of Emerging Therapies for Mild/Moderate COVID-19 C Ali, TJ Mattingly, JF Slejko, S Dosreis
228 [GO] 2022―Jun―25 OP6 Measuring and Quantifying Lost Productivity Due to Priority Diseases: A Review of the Past 10 Years and Reflections on the Unprecedented Changes and Implications Emerging with COVID-19 S Rojanasarot, NC Edwards, SK Bhattacharyya
229 [GO] 2022―Jun―25 MSR10 An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19 M Broder, SN Gibbs, I Yermilov
230 [GO] 2022―Jun―25 HSD54 Adherence to Expert Recommendations: Evidence from Oral vs. Infusion Substitution during COVID-19 Y Civelek, D Cullen, D Debono, MJ Fisch, J Barron, G Sylwestrzak
231 [GO] 2022―Jun―25 HSD49 Variability in Incidence of Circulatory and Endocrinal Complications Post COVID-19 S Choudhary, A Sethi, V Verma, L Brooks, M Sulzicki, S Pandey, et al. (+7)
232 [GO] 2022―Jun―25 CO67 Predictors of Long COVID in Patients with Severe COVID-19 - a US Healthcare Database Analysis C Holy, B Patterson, J Ruppenkamp, F Richards, R Debnath, JK DeMartino, et al. (+3)
233 [GO] 2022―Jun―25 EE422 Healthcare Costs Associated with Severe VS Moderate and Mild COVID-19 - a US Payer Perspective C Holy, B Patterson, J Ruppenkamp, F Richards, R Debnath, JK DeMartino, et al. (+3)
234 [GO] 2022―Jun―25 EE468 Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries J Shafrin, A Mubayi, K Birch, N Land, M Sotak, M Venkatachalam, et al. (+2)
235 [GO] 2022―Jun―25 EPH32 Perceived Risk of COVID-19 and Its Association with Preparedness and Preventive Practices: A Latent Class Segmentation Analysis O Mgbere, S Iloanusi, I Yunusa, NJR Iloanusi, S Gohil, EJ Essien
236 [GO] 2022―Jun―25 EE20 An Overview of Optimisation Studies on COVID-19 and Its Economic Benefits in India E Harika, M Roy
237 [GO] 2022―Jun―25 CO132 Duration of COVID-19 and Long COVID - a US Healthcare Database Analysis B Patterson, J Ruppenkamp, F Richards, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
238 [GO] 2022―Jun―25 EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports Z Alqahtani, JJ Guo, PR Wigle
239 [GO] 2022―Jun―25 HPR2 COVID-19 and the Use of Antenatal Care Services in Côte d'Ivoire, an Africa South of the Sahara's Country AR Attia-Konan, DFR Meless, K Koffi, J Kouame, MF Male, AS Pongathie
240 [GO] 2022―Jun―25 EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China D Zhou, T Shao, H Shao, Y Tu, Y Tang, J Zhou, et al. (+2)
241 [GO] 2022―Jun―25 CO146 Readmission and Mortality Following Discharge from Inpatient Treatment for COVID-19 By Mechanical Ventilation Status in Early and Late Phases of the Pandemic J Best, SV Mohan, J Jonas, L Arader, J Yeh, MJ Butler
242 [GO] 2022―Jun―25 EPH22 Prevalence and Risk Factors of Post COVID-19 Condition in Previously Hospitalized Patients in Bolivar, Colombia: An Observational Study A Lozano, F Salcedo Mejía, N Alvis Zakzuk, JC Fernandez Mercado, M Jerez Arias, J Zakzuk Sierra, et al. (+2)
243 [GO] 2022―Jun―25 EE471 Valuing the Fear of COVID-19 Contagion N Poudel, S AlMahasis, S Simpson, S Ngorsuraches
244 [GO] 2022―Jun―25 EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital LA Oliveira, R Lucchetta, F Tonin, AF Bonetti, HH Borba, A Matoso Mendes, et al. (+3)
245 [GO] 2022―Jun―25 EPH58 The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala J Kochuparambil, A Issac
246 [GO] 2022―Jun―25 PCR93 Comprehensibility and Usability of an Electronic COVID-19 Daily Symptom Diary K Baranov, C Casstevens, P McLeroth, E Merikle
247 [GO] 2022―Jun―25 EPH134 Sex-Gender Differences in COVID-19 Diagnosis, Hospitalization and Mortality S Kharroubi, M El Harakeh
248 [GO] 2022―Jun―25 P36 The Impact of COVID-19 Diagnosis on Healthcare Costs C. Morrow, RM. McKenna, L. Palmer
249 [GO] 2022―Jun―25 PCR158 Hungarians' Attitudes Toward the COVID-19 Disease and Vaccination: An Online Survey H Khatatbeh, M Zrínyi, R Vajda, Z Verzár, J Turcsán, K Takács, et al. (+3)
250 [GO] 2022―Jun―25 EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic A Tebaibia, A Mammeri, H Brahimi, M Ammi, N AitSaid, M Lebdjiri, et al. (+14)
251 [GO] 2022―Jun―25 EPH31 Disparities and Trends of COVID-19 Epidemiology in EU-5 Countries across Pandemic Waves: A Targeted Literature Review (TLR) S Kamra, J Venkateswara Rao, R Mandlik, S Dabral, R Pagidigummula, R Hyderboini, et al. (+3)
252 [GO] 2022―Jun―25 CO31 Health Equity Considerations in Minority Groups with Type 1 and 2 Diabetes in the COVID-19 Era: Care Utilizations and Costs Y Ionova, L Zhong, Y Ma, L Wilson
253 [GO] 2022―Jun―25 PCR100 COVID-19 Experiences of Pregnant and Postpartum Persons and Their Impact on Health-Related Quality-of-Life P Aytha Swathi, A Regan, NY Gu, M Nosek
254 [GO] 2022―Jun―25 MT30 Learnings from DTC Launch of a Digital Therapeutic for ADHD in Response to the COVID-19 FDA Policy for Digital Health Devices for the Treatment of Psychiatric Disorders L Palko
255 [GO] 2022―Jun―25 HTA56 COVID-19 from the Perspective of Intellectual Property CR Pereira da Veiga, C Da Veiga, R Arcaro
256 [GO] 2022―Jun―25 EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia R Montejano, F Riera, C Falistocco, L Espinoza, A Azamar-Alonso
257 [GO] 2022―Jun―25 EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network K Moll, S Hobbi, CK Zhou, K Fingar, T Burrell, V Hernandez-Medina, et al. (+5)
258 [GO] 2022―Jun―25 EPH135 The Effect of Lockdown on Reducing Hospitalisations Associated with COVID-19 in Australia S Choi, H Kim
259 [GO] 2022―Jun―25 HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil R Arcaro, C Da Veiga, CR Pereira da Veiga
260 [GO] 2022―Jun―25 RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD) A Kolbin, GI Syraeva, SA Mishinova
261 [GO] 2022―Jun―25 EE495 Threshold Price in the US to Achieve Cost-Effective Use of Molnupiravir and PF-07321332/Ritonavir for the Prevention of Severe COVID-19 in High-Risk Adults T Majda, D Veenstra
262 [GO] 2022―Jun―25 EPH51 Associations between Psychiatric Disorders and COVID-19 in Japan: Results from the Life Study F Murata, M Maeda, H Fukuda
263 [GO] 2022―Jun―25 EE99 Economic Burden of COVID-19 in Mexico AE Frias Gasga, VU Delgadillo Hernández, H Soto Molina, S Guzman Vazquez
264 [GO] 2022―Jun―25 EE335 The Hospitalization Burden of COVID-19 in Patients with NSCLC: Differential Impact of Vaccination F Richy, D Kumar, D Kulkarni
265 [GO] 2022―Jun―25 EE467 Recovid Study. Cost-Effectivness Analysis of Using Nutridrink 200 ML in the Treatment of COVID-19 in the Hospital M Frolov
266 [GO] 2022―Jun―25 PCR77 Using Twitter to Examine Public Perceptions about COVID-19 in the United States: A Sentiment Analysis AA Ali, K Adjei, S Fatimah, K Ezendu, M Taeb, H Chi, et al. (+2)
267 [GO] 2022―Jun―25 EE225 Economic and Clinical Impact of a Novel, Antiviral Therapy on COVID-19 in the US S Gibson, R Saunders, N Stasko, C Brown-Bickerstaff, J Oakley, M Osterman, et al. (+4)
268 [GO] 2022―Jun―25 P60 The Association between Statin Use and Severe Outcomes in COVID-19 Infected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, E. Pittman, S. Ramachandran, J. Bentley, B. Banahan, T. Kirby, et al. (+2)
269 [GO] 2022―Jun―25 EE330 Spill-over of Medical Cost for Blue Cross and Blue Shield of Louisiana Members with Differing Severity of COVID-19 Infection E Lucas, S Palanki, M Liu, D Barfield, Y Zhang, B Vicidomina, et al. (+2)
270 [GO] 2022―Jun―25 EPH20 Does a Mother's Previous Experience with COVID-19 Infection Change Her Intention to Vaccinate Her Children M Zakeri, J Li, EJ Essien, SS Sansgiry
271 [GO] 2022―Jun―25 P35 Risk of Psychiatric and Neurological Sequelae after the COVID-19 Infection: A Retrospective Cohort Study Using Claim Data A. Gaur, I. Kukreja, N. Mishra, A. Roy, A. Chopra, A. Gupta, et al. (+6)
272 [GO] 2022―Jun―25 P34 Identifying Interventions That Reduced COVID-19 Mortality in Long-Term Care Facilities: A Causal Inference Analysis R. Goldberg
273 [GO] 2022―Jun―25 CO139 Use of Remdesivir Among Hospitalized Patients with Severe COVID-19: Analysis of Electronic Health Records from Trinetx COVID-19 Network F Wolde, L Gressler
274 [GO] 2022―Jun―25 RWD69 The Impact of COVID-19 on Colorectal Cancer Screening in Northern Ireland Z Waller, E McFerran, F Lamrock, M Lawler, F Bannon
275 [GO] 2022―Jun―25 SA43 The Impact of COVID-19 on Managing Clinical Trials PP Gannavarapu, KV Mandello
276 [GO] 2022―Jun―25 SA34 Impact of COVID-19 on Telehealth Utilization: Analysis of Komodo Healthcare Map™ Claims Data A Silber, R Liu, M Mulrooney, M Salkar, K Francis, N Hadker
277 [GO] 2022―Jun―25 HSD64 The Influence of COVID-19 on Telemedicine Services Among Blue Cross and Blue Shield of Louisiana Members with Diabetes H Zhang, E Lucas, M Kiggans, Y Zhang, B Vicidomina, S Mills, S Nigam
278 [GO] 2022―Jun―25 MSR49 Assessing the Impact of COVID-19 on the Healthcare Resource Utilization and Treatment in High Incidence Oncological Conditions K Paul, V Verma, U Parashar, L Brooks, M Sulzicki, S Pandey, et al. (+7)
279 [GO] 2022―Jun―25 RWD70 Impact of COVID-19 on the Utilization of Behavioral Healthcare Services in the US I Kukreja, N Mishra, A Gaur, A Roy, A Chopra, A Gupta, et al. (+6)
280 [GO] 2022―Jun―25 RWD134 Impact of COVID-19 on the Utilization of Screening and Therapy Services for Children with Autism in the US N Mishra, M Rawat, A Gaur, I Kukreja, A Roy, A Chopra, et al. (+7)
281 [GO] 2022―Jun―25 EPH129 Blue Cross and Blue Shield of Louisiana's COVID-19 Outbreak Simulation- Deterministic SEIR Modeling M Cong, J Holloway, M Liu, E Lucas, Y Zhang, J Ouyang, et al. (+2)
282 [GO] 2022―Jun―25 EPH45 The Impact of Gingivitis and Periodontitis on COVID-19 Outcomes: A Case-Control Study C Morrow, RM McKenna, E Gebauer, L Palmer
283 [GO] 2022―Jun―25 HPR55 How Inequities and Disparities in Health & Healthcare Are Impacting COVID-19 Outcomes: A Scoping Review KJ Craig, TJ Bright, H Karunakaram, C VanHouten, Y Akdas, I Dankwa-Mullan
284 [GO] 2022―Jun―25 PCR103 A Digitally Enabled Care and Real World Evidence (RWE) Research Program Among Individuals with Asthma and COPD during the COVID-19 Pandemic R Willmon, O George, S Selvarajah, J Adams, G Soyao, M Hart, et al. (+2)
285 [GO] 2022―Jun―25 OP8 Trends in General Surgery Procedure Volumes By Modality during the COVID-19 Pandemic S Wing, A de Groot, Y Liu, Y Li
286 [GO] 2022―Jun―25 HSD47 Malignant Surgical Volumes and Length of Stay By Modality during the COVID-19 Pandemic S Wing, A de Groot, Y Liu, Y Li
287 [GO] 2022―Jun―25 EPH160 Burden of Frequent Mental Distress in the US Population during the COVID-19 Pandemic NHK Le
288 [GO] 2022―Jun―25 EPH117 Factors Associated with Receipt of Second Dose of mRNA-1273 Vaccine at Walgreens Pharmacies during the COVID-19 Pandemic E Roberts, A Shah, R Smith-Ray, P Buck, N Van de Velde, C Talarico, et al. (+2)
289 [GO] 2022―Jun―25 EPH35 Information Seeking and Preventive Behavior during the COVID-19 Pandemic T Park, I Ju, J Ohs, A Hinsley, J Muzumdar
290 [GO] 2022―Jun―25 PCR15 The Impact of the COVID-19 Pandemic and Lockdowns on the Health-Related Quality of Life of People Living with Multiple Sclerosis in Australia G Henson, I van der Mei, BV Taylor, P Blacklow, SB Claflin, AJ Palmer, et al. (+2)
291 [GO] 2022―Jun―25 EPH92 Investigating Undergraduate Students’ Perception on COVID-19 Pandemic and Social Distance and Its Influencing Factors By Association Analysis and Sentimental Analysis K Lee, S Han, L Osipenko, HS Suh
292 [GO] 2022―Jun―25 HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers? É Gaudette, Y Zhang
293 [GO] 2022―Jun―25 PCR64 COVID-19 Pandemic Effect Estimation, in Medical Attention on Patients with Gynecological Cancer and Their Caregivers in Mexico F Morales, S Guzmán Vázquez, K Torres Méndez, H Soto
294 [GO] 2022―Jun―25 HSD88 Fruit and Vegetable Consumption in Hungary during the Fall of COVID-19 Pandemic in 2020 B Tisza, T Stromájer-Rácz, Z Verzár, I Boncz, A Pakai, A Gubicskóné Kisbenedek
295 [GO] 2022―Jun―25 HTA2 RAPID C-19: Achievements and Challenges of a Collaborative Response to the COVID-19 Pandemic in the UK A Greenwood, A Brett, N Umeweni, S Upadhyaya
296 [GO] 2022―Jun―25 MSR29 Predicting Panel Attrition in Longitudinal HRQoL Surveys during the COVID-19 Pandemic in the US T Yu, J Chen, NY Gu, JW Hay, CL Gong
297 [GO] 2022―Jun―25 CO136 COVID-19 Pandemic Indirect Impact on Mortality Rates D Araja
298 [GO] 2022―Jun―25 EPH43 Impact of COVID-19 Pandemic on Cancer Preventive Screening D Weeraratne, A Rajmane, M Patel, B Rosario
299 [GO] 2022―Jun―25 HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients Y Shao, L Shi, E Nauman, E Price-Haywood, C Stoecker
300 [GO] 2022―Jun―25 HSD98 Estimating the Impact of the COVID-19 Pandemic on Healthcare Waiting Lists in England R King, A Pijper, A Marsland, R Sloan, S Holloway, B Bray, J Pearson-Stuttard
301 [GO] 2022―Jun―25 HSD19 Impact of Coronavirus Disease (COVID-19) Pandemic on Non-COVID Healthcare Utilization in Saudi Arabia R Alameddine, Y Bassil, J Barhoun, K Asmar, C Maskineh, H Al-Omar
302 [GO] 2022―Jun―25 HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia Z Liu, CA Patel, A Campbell, A Fu, C Benson
303 [GO] 2022―Jun―25 P33 Evaluating the Impact of the COVID-19 Pandemic on the Diagnosis and Staging of New Breast Cancer Cases: A Retrospective Analysis of Medical Chart Data from the United States R. Knapp, F. Hardtstock, T. Wilke, B. Boner, C. Hurmiz, A. McCracken
304 [GO] 2022―Jun―25 RWD26 Real World Evidence for the Impact of COVID-19 Pandemic on the Incidence of Multiple Myeloma in Germany S Schilling, G Azarias, L Merker, K Strobel, S Wischlen, L Kellermann
305 [GO] 2022―Jun―25 RWD117 Impact of COVID-19 Pandemic on the Romanian Breast Cancer Burden: A County Population-Based Study A Turcu-Stiolica, MS Subtirelu, M Bogdan, VC Dinescu, V Gheorman, M Aldea, et al. (+2)
306 [GO] 2022―Jun―25 EPH86 Effect of the COVID-19 Pandemic on the Utilization of Hospice-Palliative Care Services in Hungary M Lukács, A Siket, M Zrínyi, I Karácsony, I Boncz, A Pakai
307 [GO] 2022―Jun―25 CO109 Increase in All-Cause Mortality Rate for Patients Admitted to the Emergency Department (ED) with Myocardial Infarcts during COVID-19 Pandemic Regardless of ST Elevation A Braendle, K Lodaya, X Zhang, J Lilley, S Munson, F D'Souza
308 [GO] 2022―Jun―25 PCR116 Exploring the Known-Group Validity between EQ-5D-5L and GAD-7 during Hong Kong COVID-19 Pandemic Situation CW Ng, E Wong, AWL Cheung
309 [GO] 2022―Jun―25 PCR16 Stroke Rehabilitation Treatment Preferences of Chinese Physicians and Patients during the COVID-19 Pandemic: A Discrete Choice Experiment G Feng, D Hao, T Liu, X Fang, N Yan, Q Chen, et al. (+6)
310 [GO] 2022―Jun―25 EPH100 Assessment of Psychological Responses of the Indian Population Due to COVID-19 Pandemic: A Web-Based Survey RV Rajesh, A Anand, J Sebastian, J Lucca
311 [GO] 2022―Jun―25 SA44 Trends in Medication Error Reporting during the COVID-19 Pandemic: An Analysis of Faers Data, 2016 to 2021 V Wysocki, DW Grabe, PD Meek
312 [GO] 2022―Jun―25 EPH6 Health-Related Quality of Life (HRQOL) Among Chinese Population during the COVID-19 Pandemic: The Role of Socio-Demographic Factors and Loneliness E Wong, J Li, S Yuen, AHY Lai, AWL Cheung, PSY Yau, EK Yeoh
313 [GO] 2022―Jun―25 RWD31 Comparison of Remdesivir As Monotherapy or in Combination with Steroids in Treating COVID-19 Patients M Rawat, S Choudhary, A Gaur, V Verma, I Kukreja, A Roy, et al. (+7)
314 [GO] 2022―Jun―25 EPH40 Characteristics of COVID-19 Patients Admitted to the University Hospital of El Biar in Algiers during the First 6 Months of the Epidemic in Algeria: Descriptive Study of 1008 Cases A Tebaibia, A Mammeri, H Brahimi, M Ammi, N AitSaid, M Lebdjiri, et al. (+14)
315 [GO] 2022―Jun―25 PCR55 Analyzing the Relationship between Social Determinants of Health (SDOH) on Hospital Capacity for COVID-19 Patients By Geographic Region K Watkins, S Strickland, K Prudyus, K Rademacher
316 [GO] 2022―Jun―25 HSD104 Antibiotics Dispensed at Drugstores for Mild Cases of COVID-19 Patients in Northern Punjab, Pakistan U Malik, F Hashmi, N Atif, F Khan, Y Fang
317 [GO] 2022―Jun―25 EE349 Remdesivir Use in Hospitalized COVID-19 Patients in the United Arab Emirates: A Cost-Effectiveness and Health Care Resource Use Model A Subhi, A Mohamed El Shamy, SA Hussein, J Jarrett, S Kozma, C Harfouche, MA Sara Ahmad
318 [GO] 2022―Jun―25 RWD16 Impact of COVID-19 Vaccination in Reducing Average Length of Stay in Hospitals Among COVID-19 Patients in the US - a Retrospective Study from De-Identified Administrative Claims Database N Pandey, V Verma, A Chopra, I Kukreja, A Gaur, M Sulzicki, et al. (+6)
319 [GO] 2022―Jun―25 EPH132 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the US: How Did It Change in 2021 from ALPHA to DELTA Variant? R Moon, N Rosenthal
320 [GO] 2022―Jun―25 EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community A Metry, R Rafia, A Wailoo
321 [GO] 2022―Jun―25 EE415 Spatial Cost-Efficiency Analysis on the Separability Condition of COVID-19 Potential Determinants T Nepomuceno, A De Lima
322 [GO] 2022―Jun―25 SA6 A Review of Economic Evaluation on Vaccination and Non-Pharmaceutical Interventions for COVID-19 Prevention and Control J Zhao, Y Fu, P Han, L Yang
323 [GO] 2022―Jun―25 EPH167 Recursive Partitioning Analysis of COVID-19 Risk and Behavioral Measures in an Urban Setting O Mgbere, S Iloanusi, I Yunusa, NJR Iloanusi, S Gohil, EJ Essien
324 [GO] 2022―Jun―25 RWD57 Emergency and Inpatient COVID-19 Service Utilization and Its Stratification Based on Comorbid Conditions S Choudhary, A Gaur, I Kukreja, A Roy, A Chopra, A Gupta, et al. (+6)
325 [GO] 2022―Jun―25 RWD2 Variation in COVID-19 Treatment Cost due to Social Factors in the US - Estimation Using Integration of CDC/ATSDR’s Social Vulnerability Index (SVI) and Healthcare Claims Data A Roy, A Gaur, A Gupta, N Upadhyay, I Kukreja, A Chopra, et al. (+7)
326 [GO] 2022―Jun―25 EE386 Cost-of-Illness Analysis of Coronavirus Disease 2019 (COVID-19) Treatment in the Philippine General Hospital RM Castillo, V Chuabio, CI Panelo, C Jimeno
327 [GO] 2022―Jun―25 HSD5 Changes in COVID-19 Treatment Patterns over the Course of 2020 BA Turner, J Winer-Jones, A Maresca
328 [GO] 2022―Jun―25 EPH103 COVID-19 Vaccination Among Pregnant Women in the US: A Systematic Review S Rawal, RL Tackett, RH Stone, HN Young
329 [GO] 2022―Jun―25 HSD60 Children's COVID-19 Vaccination and Race - a Nationwide Survey of Children's Vaccination Status and Trust in the U.S. General Population E Heidari, CM Brown, R Morlock, K Blakomer, A Morlock
330 [GO] 2022―Jun―25 EPH60 Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US L Kallenbach, S Whipple, M Bonafede
331 [GO] 2022―Jun―25 HPR36 Using Best-Worst Scaling to Identify the Important Barriers to COVID-19 Vaccination in Black Belt Region: A Pilot Study H Yang, N Poudel, S Simpson, C Chou, S Ngorsuraches
332 [GO] 2022―Jun―25 EE71 Cost-Effectiveness of COVID-19 Vaccination in Colombia: A Micro-Simulation Modelling Analysis C Castañeda-Orjuela, N Alvis-Zakzuk, D Diaz-Jimenez, N Alvis-Guzman
333 [GO] 2022―Jun―25 P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study B. Jahn, G. Sroczynski, M. Bicher, C. Rippinger, N. Mühlberger, J. Santamaria, et al. (+3)
334 [GO] 2022―Jun―25 P10 Parental Vaccine Sentiment and Decision-Making Factors for Pediatric COVID-19 Vaccinations B. Wu, R. Almeida, N. Eslami, S. Garfield
335 [GO] 2022―Jun―25 HSD117 Sociodemographic Disparities in COVID-19 Vaccinations Still Exist 1 Year Following Vaccine Rollout J Rizk, FT Shaya
336 [GO] 2022―Jun―25 P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States M. Liu, A.C. Wong, J.T. McPheeters, R. Dixon, V. Madge, G. Basra, et al. (+2)
337 [GO] 2022―Jun―25 EPH75 COVID-19 Vaccine Breakthrough Infections in the United States, By Race M Liu, AC Wong, JT McPheeters, R Dixon, V Madge, G Basra, et al. (+2)
338 [GO] 2022―Jun―25 P15 Drivers of Health Disparities and Consequences for COVID-19 Vaccine Choices: Modelling Health Preference Heterogeneity Among Underserved Populations E. Van Den Broek-Altenburg, J. Benson, A. Atherly, S. Hess
339 [GO] 2022―Jun―25 EE188 COVID-19 Vaccine Hesitancy Among Early Adaptors in Jordan S Muflih
340 [GO] 2022―Jun―25 P14 Identification of COVID-19 Vaccine Hesitancy Predictors E. Saldarriaga
341 [GO] 2022―Jun―25 EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England S Aballea, P Karwala, I Zerda, M Toumi, M Pochopien, B Borissov, E Clay
342 [GO] 2022―Jun―25 EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5-17 Years: A Study of Reports from the VAERS Database Y Lee, A Gómez-Lumbreras, MS Tan, DC Malone, L Villa Zapata
343 [GO] 2022―Jun―25 SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population CY Shim, H Ghani, L Ahmad, H Sharif, MF Alikhan, S Bagol, et al. (+11)
344 [GO] 2022―Jun―25 EE7 Economic Evaluation of COVID-19 Vaccines: A Targeted Literature Review A Addae, L Ramjee, G Tremblay
345 [GO] 2022―Jun―25 EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS) AK Alahmari, Z Almalki, A Alshehri, AA Albassam, NJ Ahmed
346 [GO] 2022―Jun―25 EE238 Healthcare Costs of COVID-19 Versus Flu and Pneumonia - a Payer Perspective F Richards, B Patterson, J Ruppenkamp, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
347 [GO] 2022―Jun―25 RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine A Kolbin, SA Mishinova, GI Syraeva, YS Polushin
348 [GO] 2022―Jun―25 EPH55 Association Between Prior Bisphosphonate Use and COVID-19-Related Outcomes J Thompson, Y Wang, T Dreischulte, O Barreiro, R Gonzalez, P Hanč, et al. (+6)
349 [GO] 2022―Jun―25 EE456 Healthcare Resource Utilization Among Patients with Glycogen Storage Disease Type Ia (GSDIa) in the United States and the Impact of COVID-19: A Claims Database Analysis J Nedzesky, E Kruger, RN Gupta, NA Thomas, V Valayannopoulos
350 [GO] 2022―Jun―25 EE450 Treatments and Diagnostics for COVID-19: A Living Systematic Review of Economic Evaluations J Elvidge, A Summerfield, D Nicholls, D Dawoud
351 [GO] 2022―Jun―25 RWD44 Post-COVID Syndrome in Hospitalized Patients with COVID-19: A Prospective Cohort Study from a Health Care Plan in Brazil J Busch, J DOS Reis Neto
352 [GO] 2022―Jun―25 SA5 The Effectiveness and Safety of Remdesivir for COVID-19: A Quantitative Meta-Analysis AF Mohamed, P Duong, T Shah, M Zhang, RA Mekary
353 [GO] 2022―Jun―25 HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites P Rojas, C Epp, L Gozzo, D Geba, M Epstein, S Michel
354 [GO] 2022―Jun―25 HPR62 Economic Evaluations of Public Health Interventions on COVID-19: A Systematic Review A Rayanakorn, SL Leong, P Chaiprom, S Lee
355 [GO] 2022―Jun―25 EE334 Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with Coronavirus Disease 2019 F Richards, B Munoz, MW Fried, HL Morris, AR Mospan, JM Crawford, et al. (+4)
356 [GO] 2022―Jun―25 EPH121 A Descriptive Study on Hospital-Related Coronavirus Disease 2019 (HRCOVID-19) Among Chronic Kidney Disease Patients during the Pandemic at a Tertiary Center in the Philippines IMD Cruz, M Mendoza
357 [GO] 2022―Jun―25 EE483 The Economic Impact of Coronavirus Pandemic on Stroke Care: Direct and Indirect Costs Estimations in Chile D Paredes, R Lenz, K Hernández, L Paez
358 [GO] 2022―Jun―25 EPH140 SARS-COV-2 Breakthrough Infections Among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in the South Indian State of Kerala A Issac, J Kochuparambil
359 [GO] 2022―Jun―25 EPH137 Digital Health Solutions for Workers: Engagement with a Digital Tool for Management of SARS-COV-2 Exposure and Infection TB Gibson, L Schubel, V Assibey-Mensah, S Bloemers, C Pack, E Roemer, et al. (+4)
360 [GO] 2022―Jun―25 EPH120 Comparing the Effectiveness and Cost-Effectiveness of SARS-COV-2 Screening Strategies Using Rapid Antigen Tests in a Residential College Campus H Smolen, A Johnston, L Smolen, Y Yih
361 [GO] 2022―Jun―25 RWD72 SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS J Overcash, N Nguyen
362 [GO] 2022―Jun―25 EE43 Budget Impact Analysis of Favipiravir (AVIGAN®) for the Treatment of Patients with Confirmed Infection with SARS-COV2 in Mexico JÁ Paladio Hernández, BA Godina-Ortiz, A Lara-Terrazas
363 [GO] 2022―Jun―25 MT29 Optimal Strategies for Diabetic Foot Care in Times of Pandemic V Riquelme-Hidalgo, C Huiriqueo-Carrizo, K Reynaldos-Grandón
364 [GO] 2022―Jun―25 HSD16 Trends in Rheumatology Patient Care and Practice Operations Pre- and Post-COVID-19 Pandemic K Savill, A Klink, C Brown-Bickerstaff, Y Jeune-Smith, B Feinberg
365 [GO] 2022―Jun―25 PCR113 Depression Fallout from the Pandemic in a Sample of the Middle Eastern and North African (MENA) Community in Houston Texas, USA B Fatima, Z Majd, S Zeidat, F Atrooz, G Alrousan, S Abughosh, S Salim
366 [GO] 2022―Jun―25 HSD42 Trends in Non-COVID Healthcare Utilization during the Pandemic in Lebanon R Alameddine, Y Bassil, J Barhoun, K Asmar, C Maskineh
367 [GO] 2022―Jun―02 A Simulation-Based Cost-Effectiveness Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Prevention Strategies for Visitors of Healthcare Institutions Christina C. Bartenschlager, Selin Temizel, Alanna Ebigbo, Vivian Gruenherz, Petra Gastmeier, Helmut Messmann, et al. (+2)
368 [GO] 2022―May―06 “Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs Douglas C. Cheung, Karen E. Bremner, Teresa C.O. Tsui, Ruth Croxford, Lauren Lapointe-Shaw, Lisa Del Giudice, et al. (+11)
369 [GO] 2022―May―05 Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands Niek Mouter, Sander Boxebeld, Roselinde Kessels, Maarten van Wijhe, Ardine de Wit, Mattijs Lambooij, Job van Exel
370 [GO] 2022―Apr―28 Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials Stijntje W. Dijk, Eline M. Krijkamp, Natalia Kunst, Cary P. Gross, John B. Wong, M.G. Myriam Hunink
371 [GO] 2022―Apr―27 Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic Kandice A. Kapinos, Jordan R. Salley, Andrew Day
372 [GO] 2022―Apr―26 Americans’ Health Priorities During the COVID-19 Pandemic Joseph Cook, Melissa Pittaoulis, Kim Gilchrist, Justine Alderfer, Molly Sapia
373 [GO] 2022―Apr―12 Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic Rodrigo Murteira, Sónia Romano, Inês Teixeira, Carolina Bulhosa, Sérgio Sousa, Maria Inês Conceição, et al. (+3)
374 [GO] 2022―Apr―06 A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-health Impacts and Distributional Issues Meghan I. Podolsky, Isabel Present, Peter J. Neumann, David D. Kim
375 [GO] 2022―Apr―04 COVID-19 Health Economics: Looking Back and Scoping the Future Maarten J. Postma, Jagpreet Chhatwal
376 [GO] 2022―Mar―30 Update on a Model to Minimize Population Health Loss in Times of Scarce Surgical Capacity During the COVID-19 Crisis and Beyond Benjamin Gravesteijn, Eline Krijkamp, Anouk van Alphen, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, et al. (+8)
377 [GO] 2022―Mar―23 Electronic Patient Symptom Management Program to Support Patients Receiving Cancer Treatment at Home During the COVID-19 Pandemic Debra Wujcik, William N. Dudley, Matthew Dudley, Vibha Gupta, Jeannine Brant
378 [GO] 2022―Mar―19 Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing? Jagpreet Chhatwal, Anirban Basu
379 [GO] 2022―Feb―24 Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study Zhenyuan Chen, Xiaoxv Yin, Xiangping Tan, Jing Wang, Nan Jiang, Mengge Tian, et al. (+4)
380 [GO] 2022―Feb―20 A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales Rachid Rafia, Marrissa Martyn-St James, Sue Harnan, Andrew Metry, Jean Hamilton, Allan Wailoo
381 [GO] 2022―Feb―19 The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19 Melanie D. Whittington, Steven D. Pearson, David M. Rind, Jonathan D. Campbell
382 [GO] 2022―Feb―17 Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals Rena C. Moon, Harold Brown, Ning Rosenthal
383 [GO] 2022―Feb―16 Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations Jamie Elvidge, Ashley Summerfield, David Nicholls, Dalia Dawoud
384 [GO] 2022―Feb―05 Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World Rafael Dal-Ré, Magí Farré, M. Isabel Lucena
385 [GO] 2022―Feb―03 Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands Bram Wouterse, Frederique Ram, Pieter van Baal
386 [GO] 2022―Jan―20 P26 The Practice of Face Masking Among Young Adults in South India: An Online Cross-Sectional Survey During Second Wave of COVID-19 J Kochuparambil, A Issac
387 [GO] 2022―Jan―20 POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19 S Jhamb, S Khan, H Taneja, A Sachdev, D Mazumder, A Buikema
388 [GO] 2022―Jan―20 POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19 E Mozaffari, Z Zhang, M Thrun, RL Gottlieb, DR Kuritzkes, PE Sax, et al. (+5)
389 [GO] 2022―Jan―20 POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19. A Santos, ÉSD Gonçalves, AJF Oliveira, DB Lima, KVMDS Noronha, MV Andrade
390 [GO] 2022―Jan―20 POSA424 Challenges of COVID-19 Research: Results from a Systematic Literature Review on COVID-19 and Asthma or COPD S Grieve, P Daniele, AP Rabe, A Forsythe
391 [GO] 2022―Jan―20 POSB398 Kaplan-Meier Survival Curves Analysis of Hospitalized COVID-19 Beneficiaires of a Health Care Plan in Brazil JP Reis Neto, J Busch
392 [GO] 2022―Jan―20 POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States V Madge, N Bhardwaj, D Mazumder
393 [GO] 2022―Jan―20 P61 COVID-19 Concerns Experienced by Pregnant and Postpartum Women and Their Influence on Health-Related Quality-of-Life Swathi P Aytha, A Regan, E Grinshteyn, M Nosek, NY Gu
394 [GO] 2022―Jan―20 POSB266 NICE Published Oncology Recommendations: What Progress Has Been Made During the COVID-19 Era? E Samuels, M Tang
395 [GO] 2022―Jan―20 POSB425 Methodological Challenges to Coronavirus Disease (COVID-19) Evidence Generation to Inform Health Technology Assessment (HTA) K Rtveladze, J Gaultney, CJ Crossman-Barnes, S Kamra, D Wright
396 [GO] 2022―Jan―20 POSA383 Identification of Risk Factors Associated with COVID-19 Hospitalization A Chopra, A Arora, I Kukreja, A Gupta, V Verma, A Shukla
397 [GO] 2022―Jan―20 P6 Projecting COVID-19 Hospitalizations and Deaths Under Scenarios of Vaccination in Jefferson County, Kentucky N Patel
398 [GO] 2022―Jan―20 POSA394 Mortality Curves Analysis of COVID-19 Hospitalizations in Oncologic Patients of a Private Health Care Plan in Brazil JP Reis Neto, J Busch, S Stefani
399 [GO] 2022―Jan―20 POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico A Ponce-de-León, A Azamar-Alonso, F Silva-Sanchez, R Chirino-Sprung, V Dominguez-Esquivel, S Rajme-López
400 [GO] 2022―Jan―20 POSC172 The Long-Term Acceptability of COVID-19 Hygiene Measures, for the UK General Population G Roberts, B English, J Mumford, A Mumford
401 [GO] 2022―Jan―20 POSA21 An In-Hospital Study to Trace the Risk Factors Associated with Adverse Drug Reactions during the Second Wave of COVID-19 in a Secondary Care Hospital in India J Kochuparambil, A Issac
402 [GO] 2022―Jan―20 POSA420 Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database Z Icten, M Friedman, J Menzin
403 [GO] 2022―Jan―20 POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany JA Gossmann, C Meier, RA Greiner, J Otto, E Shlaen, A Batscheider
404 [GO] 2022―Jan―20 POSA393 Online Risk Calculator Using Machine Learning for Prediction of Survival After Hospital Discharge from COVID-19 Infection JP Reis Neto, J Busch, FN Barcellos Filho, EMJDM Farina, MCM Ferreira
405 [GO] 2022―Jan―20 POSC324 Clinical Pharmacist Intervention to Improve the Administration of Injectable Antiviral Agents By Nurses in the Treatment of COVID-19 Infection. A Nidha, J Kochuparambil, A Issac
406 [GO] 2022―Jan―20 POSA384 Identification of Complications Associated with COVID-19 Infection from Claims Data A Arora, A Chopra, I Kukreja, V Verma, A Shukla
407 [GO] 2022―Jan―20 POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project Esposti L Degli, A Ghigi, DD Ancona, M Andretta, A Barbieri, F Bartolini, et al. (+16)
408 [GO] 2022―Jan―20 POSA173 Onset of Stroke in Patients with Post-COVID-19 Syndrome Following Hospitalisation for Severe COVID-19 Infection: A Systematic Literature Review C Fleming, A Chakraborty, T Jaiswal, P Patel, S Nair
409 [GO] 2022―Jan―20 POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients R Burruss, V Arikian, K Oleru, T Traurig, M Stranz, J Lindhorst
410 [GO] 2022―Jan―20 POSC254 The Impact of COVID-19 on European HTA Decisions C Watson, JL Petrie, JA Toomey, C Shaw
411 [GO] 2022―Jan―20 P63 Impact of COVID-19 on Health-Related Quality-of-Life in the United States, Sweden and Norway: A Cross-Country Comparison Using a Panel Survey J Chen, CL Gong, X Jiao, NK Zawadzki, U Persson, JW Hay, NY Gu
412 [GO] 2022―Jan―20 P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective J Mycka, R Dellamano, W Lobb, N Dalal, L Dellamano, E Pereira
413 [GO] 2022―Jan―20 POSC185 Healthcare Utilisation, Health Inequality and the Impact of COVID-19 on Idiopathic Pulmonary Fibrosis (IPF) Care in England: A Retrospective Cohort Study J Bevan
414 [GO] 2022―Jan―20 POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season A Ngami, F Guelfucci, F Bianic, P Net
415 [GO] 2022―Jan―20 POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States A Ngami, T Christie, G Ménin, F Guelfucci, F Bianic, P Net
416 [GO] 2022―Jan―20 P28 Impact of COVID-19 on Mental Health in Young Adults in the United States T Intermill, CL Gong, NY Gu
417 [GO] 2022―Jan―20 POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey T Denee, K Pungor, Y Kambarov, R Nissinen, J Lee, K Ampeh, F Parmeggiani
418 [GO] 2022―Jan―20 POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital L Cazin, A Ngami, L Parrenne, F le Mercier, F Guelfucci, F Bianic, et al. (+2)
419 [GO] 2022―Jan―20 P25 Impact of COVID-19 on the Health-Related Quality-of-Life of Pregnant and Postpartum Persons A Regan, P Aytha Swathi, M Nosek, NY Gu
420 [GO] 2022―Jan―20 P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data S Pacis, U Maywald, T Wilke, M Ghiani
421 [GO] 2022―Jan―20 POSB278 Modernising the Clinical Trial: A Shift to Decentralised Trials Driven By Advances in Technology and Catalysed By the COVID-19 Pandemic N Cross, N Kipentzoglou, J Whitehouse, A Satherley
422 [GO] 2022―Jan―20 P27 Vaccination Coverage Trends for Hepatitis B in Infants from the Brazilian and Colombian Expanded Immunization Program: A Real-World Analysis of COVID-19 Pandemic Impact P Lima, A Abreu, F Hernández, J Martins, B Kano, D Kashiura, G Julian
423 [GO] 2022―Jan―20 P22 COVID-19 Pandemic Impacts Volume of Evaluation & Management (E&M) Telehealth Visits within Community Oncology Practices M Karhade, N Mohammad, N Robert, N Wu, B Heller, S Alwardt, et al. (+3)
424 [GO] 2022―Jan―20 POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes S Pacis, U Maywald, T Wilke, M Ghiani
425 [GO] 2022―Jan―20 POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries ML Davis-Ajami, ZK Lu, J Wu
426 [GO] 2022―Jan―20 POSC218 Study of Antibiotic Consumption Trends in Public Pharmacies during the COVID-19 Pandemic in Ukraine O Zaliska, O Semenov, Z Zabolotnya, N Maksymovych, O Brezden, B Zaliskyy, I Mudrak
427 [GO] 2022―Jan―20 POSA233 The Indirect Health Economic Consequences of the COVID-19 Pandemic on English Hospitals: A Scoping Review D Jones, L Barham
428 [GO] 2022―Jan―20 POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies P Net, J de Renteria, F Bianic
429 [GO] 2022―Jan―20 P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany J Krieger, F Hardtstock, T Wilke, U Maywald
430 [GO] 2022―Jan―20 POSA363 Lasting Impacts of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B Halioua, A Astruc, M Gourdon, A Bombezin--Domino, L Radoszycki
431 [GO] 2022―Jan―20 POSA279 The Impact of the COVID-19 Pandemic on the MHRA’s Early Access to Medicines Scheme P Ruane, R Brown, LE Francis, L Sam
432 [GO] 2022―Jan―20 P62 The Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Melanoma - Findings from a UK Melanoma Registry M Heinrich, D Mulgina, A Kudlac, C Ouyang, M Larkin, A Ofori
433 [GO] 2022―Jan―20 POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case E Viayna, FJ Candel, D Callejo-Velasco, R Ramos, J San-Roman, P Barreiro, et al. (+5)
434 [GO] 2022―Jan―20 POSA247 Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies during COVID-19 Pandemic: A Single-Arm, Before-and-After Study R Murteira, S Romano, I Teixeira, H Galante, S Sousa, A Teixeira Rodrigues
435 [GO] 2022―Jan―20 POSB248 Medication Management Practices for Non-Communicable Diseases during the Second Wave of the COVID-19 Pandemic: A Snapshot of the European Situation P Kardas, JFM van Boven, B Wettermark, E Menditto, H Pinnock, I Tsiligianni, T Agh
436 [GO] 2022―Jan―20 POSB396 Identification of Risk Factors Associated with ICU Admission in COVID-19 Patients I Kukreja, A Chopra, A Arora, V Verma, A Shukla
437 [GO] 2022―Jan―20 POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients E Mozaffari, S Liang, HM Stewart, M Thrun, P Hodgkins, R Haubrich
438 [GO] 2022―Jan―20 POSC44 Extra Regional COVID-19 Patients Transfers: A Retrospective Analysis of Distance, Time and Cost for Train, Helicopter and Fixed-Wing Ambulances A Girault, P Chauvin, P Cucharero Atienza, N Sirven, O Grimaud
439 [GO] 2022―Jan―20 POSC1 The Influence of Diabetic History in the Prognosis of Hospitalized COVID-19 Patients: A Prospective Observational Study A Issac, J Kochuparambil
440 [GO] 2022―Jan―20 POSB103 COVID-19 Positive Patients Hospital Management in the Italian Setting: The Economic Impact LB Ferrario, F Schettini, E Porazzi, M Dalla Bona, MB Pagani, T Dezi, et al. (+8)
441 [GO] 2022―Jan―20 POSC17 A TARGETED LITERATURE REVIEW TO COMPARE COVID-19 SYMPTOM DIARIES AND PATIENT-REPORTED CONCEPT K. Jarodia, K. Scippa, K. Rudell
442 [GO] 2022―Jan―20 POSA286 Early Experience with Health Technology Assessments for COVID-19 Treatments X Sitavu-Radu, T Tulika, R Rajani, S Vasileva
443 [GO] 2022―Jan―20 POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated? A Vives, L Armand, L Radoszycki, O Wilczynski
444 [GO] 2022―Jan―20 POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study B Jahn, G Sroczynski, M Bicher, C Rippinger, N Mühlberger, J Santamaria, et al. (+3)
445 [GO] 2022―Jan―20 POSC117 A Public Health and Budget Impact Analysis (BIA) of COVID-19 Vaccination in Austria M Traunfellner, F Meyer, E Walter
446 [GO] 2022―Jan―20 POSC407 Monitoring of Reported COVID-19 Vaccination Rates in Community Oncology Settings R Harrell, A Kwon, M Karhade, N Robert, N Wu, B Heller, et al. (+3)
447 [GO] 2022―Jan―20 P20 Evaluating Preferences and the Effect of Altruism on COVID-19 Vaccine Decisions: A Discrete Choice Experiment M Kelley, EF Drabo, CL Gong
448 [GO] 2022―Jan―20 POSB193 COVID-19 Vaccine Development Pipeline: 2021 R Ahlawat, R Singhal, A Rajput, R Goyal
449 [GO] 2022―Jan―20 POSB222 Can Gene Therapy Prices Remain the Same? What We Have Learned from the COVID-19 Vaccines K Sigurðardóttir, O Sola-Morales
450 [GO] 2022―Jan―20 POSA225 Comparing the US Drug Development, Pricing, Access, and Reimbursement Strategies for COVID-19 Vaccines as a Potential Model for Novel Oncology Therapies Y Lee, K Lee, H Park, M Neese, ZM Khan
451 [GO] 2022―Jan―20 POSB328 Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living with HIV/AIDS in the Era of COVID-19: A Qualitative Experience from a Low Middle-Income Country A Ahmed, J Dujaili, A Awaisu, FK Hashmi
452 [GO] 2022―Jan―20 POSC102 High-Flow Nasal Cannula in Patients with COVID-19: Is a Cost-Effective Alternative? JM Alves Junior, D Villagelin, FE Prota, A Chrispim, C Silva, E Yamanaka, et al. (+7)
453 [GO] 2022―Jan―20 POSC413 A Systematic Review of Real-World Clinical Practice Data in COVID-19: Non-Interventional Studies S Mishinova, J Gomon, A Kolbin, VV Strizheletsky, I Ivanov
454 [GO] 2022―Jan―20 P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective M Schöttler, S Van der Schans, M Postma, C Boersma
455 [GO] 2022―Jan―20 P23 Change in Healthcare Utilisation and Inpatient Mortality in Patients Hospitalised with Heart Failure during the Coronavirus Pandemic in England: A Retrospective Cross-Sectional Study Utilising HES D Jones, L Barham
456 [GO] 2022―Jan―20 POSB178 Geographical Inequalities in Coronavirus (SARS-COV-2) Mortality in Europe D Elmer, D Endrei, T Csákvári, N Németh, L Horváth, N Danku, et al. (+2)
457 [GO] 2022―Jan―20 POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2 AF Cobre, A Junkert, MM Fachi, B Böger, M Surek, A Wiens, et al. (+2)
458 [GO] 2022―Jan―20 POSA210 Decentralized Study Methods: A Summary of the Regulatory Landscape in the SARS-COV-2 Era and Beyond A Bevan, M Baltezegar
459 [GO] 2022―Jan―20 POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection B Iacolare, V Perrone, D Sangiorgi, A Ghigi, E Giacomini, C Nappi, et al. (+16)
460 [GO] 2022―Jan―20 P24 Telehealth Access and Use by the U.S. Medicare Population during the Pandemic T Swenson
461 [GO] 2022―Jan―20 POSA234 The Value of a Large Care Network in Delivering Continuity of Care to Clinically Extremely Vulnerable People During a Global Pandemic: A UK Case Study S Boeger, E Busink, G Dewsnap, K Basnayake, M Beaumont
462 [GO] 2021―Dec―11 The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe Luz María Peña-Longobardo, Juan Oliva-Moreno, Beatriz Rodríguez-Sánchez
463 [GO] 2021―Dec―08 Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries Jichao Sun, Yefeng Zheng, Wenhua Liang, Zifeng Yang, Zhiqi Zeng, Tiegang Li, et al. (+4)
464 [GO] 2021―Oct―16 Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review Oscar Lau, Nirma Khatri Vadlamudi
465 [GO] 2021―Sep―30 Cost-Effectiveness of Coronavirus Disease 2019 Policy Measures: A Systematic Review Sophie Vandepitte, Tijs Alleman, Ingmar Nopens, Jan Baetens, Samuel Coenen, Delphine De Smedt
466 [GO] 2021―Aug―05 Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories J. Jaime Caro, Jörgen Möller, Vatshalan Santhirapala, Harpreet Gill, Jessica Johnston, Kariem El-Boghdadly, et al. (+3)
467 [GO] 2021―Aug―05 Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios William F. Vásquez, Jennifer M. Trudeau
468 [GO] 2021―Jul―31 Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic Brittany R. Lapin, Wai Hong Wilson Tang, Ryan Honomichl, Olivia Hogue, Irene L. Katzan
469 [GO] 2021―Jun―04 PNS21 Protection Motivation Theory in Predicting Intention to Engage in Protective Behaviors Against NOVEL Coronavirus Diseases (COVID-19) G. Adunlin, H. Galadima, C. Cropp, J.C. Cagle
470 [GO] 2021―Jun―04 PMU1 Evolving Access Under COVID-19 J. Cook
471 [GO] 2021―Jun―04 PNS36 VALUE Based Procurement: A Tool to Make Better Purchasing Decisions after COVID-19 G. Prada, C. Brabata, D. Guarin, R. Iunes, R. Lenz, V. Zamora Mesia
472 [GO] 2021―Jun―04 PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19 F. Kamgar, R. Hughes, S. Lucherini
473 [GO] 2021―Jun―04 PNS69 Burnout Syndrome Prevention In Nursing At Pandemic (Covid-19): A Literature Review F. Caballol-Avendaño, A. Flores-Hoyos, J. Guerra-Cruz, V. Merillu-González, F. Morales-Vizcarra, K. Reynaldos-Grandón
474 [GO] 2021―Jun―04 PCV40 Cardiovascular Outcomes Associated with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis H. Alkofide, R. Almesned, L. Alnoghaimshi, Z. Alkherb, G. Alhindi, G. Korayem
475 [GO] 2021―Jun―04 PIN52 Effectiveness in Reducing the Risk of Death and Severity of a SET of Measures Against COVID-19 : The Case of an Insured Population in the Colombian Caribbean F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
476 [GO] 2021―Jun―04 IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample V. Divino
477 [GO] 2021―Jun―04 PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24 Sands-Lincoln. M, H. Huang, G.P. Jackson, S. Wang
478 [GO] 2021―Jun―04 PNS13 Comparative Network Efficiency Analysis of Brazil Response to COVID-19 at State Level T. Nepomuceno, W.M. Silva, S.D.F. Gomes, T.F.O. Rodriguez
479 [GO] 2021―Jun―04 PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL J. Guo, J. Yang, J. Muzumdar, T. Park
480 [GO] 2021―Jun―04 PIN40 Risk Factors for Severe Outcomes in COVID-19 Confirmed or Suspected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, S. Ramachandran, E. Pittman, K. Bhattacharya, J.P. Bentley, B. Banahan, et al. (+2)
481 [GO] 2021―Jun―04 PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome D. Araja, U. Berkis, A. Lunga, M. Murovska
482 [GO] 2021―Jun―04 PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods D. Sheinson, Y. Meng, D. Elsea
483 [GO] 2021―Jun―04 PIN58 The U.S. International Trade of Medical Products in the COVID-19 Era S.M. Preciado, K. Lotfi, E. Seoane-Vazquez, R. Rodriguez-Monguio, P. Brancazio
484 [GO] 2021―Jun―04 PRS24 Utilizing Blue Cross Blue Shield of Louisiana (BCBSLA) Risk of Hospitalization (ROH) AI Predictive Model to Help Louisiana Identify Patients at High Risk for a COVID-19 Hospital Admission J. Holloway, M. Cong, J. Ouyang, B. Vicidomina, S. Nigam
485 [GO] 2021―Jun―04 PCN238 COVID-19 Impact on Breast and Prostate Cancer Screening, Diagnosis, and Surgery: A Real-World Study from the Brazilian and Colombian Public Healthcare System Perspectives P.V.P. Lima, L. van der Werf, R. Ferreira, D. Kashiura, L. Ono, G. Julian, et al. (+2)
486 [GO] 2021―Jun―04 PNS14 Direct Medical Costs Related to COVID-19 in Colombia N. Alvis-Zakzuk, A. Florez-Tanus, D. Diaz-Jimenez, P. Chaparro-Narvaez, C. Castañeda-Orjuela, F. De La Hoz, et al. (+2)
487 [GO] 2021―Jun―04 PRS21 Quantifying the years of life lost due to COVID-19 in Colombia: preliminary estimates N. Alvis-Zakzuk, N. Alvis-Guzman, D. Diaz-Jimenez, C. Dueñas Castell, J. Rojas-Suarez, J.C. Fernandez Mercado, et al. (+3)
488 [GO] 2021―Jun―04 PIN32 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in Europe and Asia E. Achter, Y. Shen, R. Goldgrub, R. Kendall, D. Shah
489 [GO] 2021―Jun―04 PDB48 Increased Mortality of COVID-19 in Patients with Diabetes: A Retrospective Cohort Study in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
490 [GO] 2021―Jun―04 PIN41 The Public Health Implications of Google Trends and News Coverage for COVID-19 in the Early Epidemic Stage: A Multinational Study in Eight Countries F. Huang, G. Feng, T. Liu, Q. Chen, T. Jian, Q. Zhong, et al. (+4)
491 [GO] 2021―Jun―04 PIN22 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in the USA Y. Shen, R. Goldgrub, E. Achter, R. Kendall, D. Shah
492 [GO] 2021―Jun―04 PIN42 Molecular Testing Dynamics Is Reactive to COVID-19 Incidence: Observations from the Colombian Experience A. Lozano, J. Zakzuk, F. Salcedo Mejía, L. Moyano, N. Alvis-Zakzuk, N.R. Alvis-Zakzuk, N. Alvis-Guzman
493 [GO] 2021―Jun―04 IN4 Non-Health Considerations in Economic Evaluations of COVID-19 Interventions: A Systemic Review M. Podolsky, D. Kim, P.J. Neumann
494 [GO] 2021―Jun―04 PIN44 COVID-19 Knowledge, and Mental Health IMPACT Assessment in Haiti Y. Gousse, T. Jean
495 [GO] 2021―Jun―04 PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study P.B. Samaksha, R.K. Puvvada
496 [GO] 2021―Jun―04 PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis E. Guidotti, S. Manetti, M. Vainieri, F. Attanasio, N. Orsini
497 [GO] 2021―Jun―04 PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria F. Fatoye, T. Gebrye, O.O. Arije, C. Fatoye, O. Onigbinde, C. Mbada
498 [GO] 2021―Jun―04 PIN77 Engagement in Preventive Behaviors Following Exposure to COVID-19 News on Social Media T. Park, I. Ju, J. Ohs, A. Hinsley, J. Muzumdar
499 [GO] 2021―Jun―04 PMU48 The IMPACT of COVID-19 on European Health Technology Assessments P. Wagner, J. Zlateva, A. van Engen, S. Plantör
500 [GO] 2021―Jun―04 PMU45 The Impact of COVID-19 on Patient Management across the EU and US J. Piercy, E.A. Holdsworth, J. Austin, M.J. Hughes, K. Khela, G. Taylor-Stokes, J. Hall
501 [GO] 2021―Jun―04 PNS67 Gaining Trust in the Use of Virtual Meetings for Health Technology Assessment during the COVID-19 Pandemic J. Dickson, M. Pierre, L. Lockhart, J. McCormack
502 [GO] 2021―Jun―04 PNS56 Survey of the Awareness of Pharmacists about Quarantine Measures during the COVID-19 Pandemic O. Semenov, O. Zaliska, N. Maksymovych, V. Huz, Z. Zabolotnya
503 [GO] 2021―Jun―04 PMU58 Americans' Health Priorities during the COVID-19 Pandemic J. Cook, M. Pittaoulis, K. Gilchrist, J. Alderfer, M. Sapia
504 [GO] 2021―Jun―04 PMH24 Demographic and Clinical Factors Associated with Post Traumatic Stress Disorder (PTSD) during the COVID-19 Pandemic B.L. Rosario, H. Huang, G.P. Jackson, B. Kolt, S. Wang
505 [GO] 2021―Jun―04 PIN8 Application of Innovative Pricing in Response to the COVID-19 Pandemic C. Akunne, B. Connelly, S. Bathija
506 [GO] 2021―Jun―04 PDB28 Innovative Application of a Mobile APP for Gestational Diabetes Health Education in the Era of the COVID-19 Pandemic and BIG DATA G. Feng, F. Huang, Q. Chen, Q. Zhong, T. Liu, D. Hao, et al. (+3)
507 [GO] 2021―Jun―04 PRS32 Management Of The Covid-19 Pandemic Around Public Health: Ethical Perspectives C. Alcayaga, V. Loor-Sánchez, N. Oyarce-Hormazábal, M.P. Riveros-Riveros, K. Reynaldos-Grandón
508 [GO] 2021―Jun―04 PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
509 [GO] 2021―Jun―04 PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil? R. Arcaro, C.R. Pereira da Veiga, C. Da Veiga
510 [GO] 2021―Jun―04 PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia J. Pesa, J.N. Liberman, M. Petrillo, C. Ruetsch
511 [GO] 2021―Jun―04 PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization P. Arora, J. Ha, D. Mehta
512 [GO] 2021―Jun―04 PUK19 DATA Quality Considerations for Determining the IMPACT of the COVID-19 Pandemic on Outpatient Visits and Procedures in the United States P. Brendel, R. Jain, A. Lien, D. Lee, J.B. Shelton, R. Fang, et al. (+4)
513 [GO] 2021―Jun―04 PMU63 Post-Lockdown Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in the United States B. Halioua, J. Zetlaoui, A. Astruc, M. Harrizi, A. Bombezin--Domino, L. Radoszycki
514 [GO] 2021―Jun―04 PIN20 Predicting the IMPACT of Vaccination Strategies in the COVID-19 Pandemic Using a Susceptible-Exposed-Infectious-Removed (SEIR) MODEL W. Song, Y. Yi
515 [GO] 2021―Jun―04 PCN120 Clinical and Economic Consequences of Delayed Care Due to the COVID-19 Pandemic- Focus on Mammograms and Breast Cancer K. Infante, N. Eslami, S. Garfield
516 [GO] 2021―Jun―04 PIN47 COVID-19 Patient Severities in Japanese EMR M. Okada, S. Wada, M. Isshiki, S. Utsunomiya, T. Akiyama, K. Hamada, S. Demiya
517 [GO] 2021―Jun―04 PIN74 Health-Related Quality of Life (HRQoL) in COVID-19 Patients - a Systematic Literature Review N. Goli, N. Kayam, N. Kumar, D. Shah
518 [GO] 2021―Jun―04 PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases S.W. Kim, T. Ishii, S. Takeno, Y. Kado, Y. Tamai, T. Akiyama, et al. (+2)
519 [GO] 2021―Jun―04 PIN64 Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System V. Kumar, L. Rasouliyan, S. Long, M.B. Rao
520 [GO] 2021―Jun―04 IN1 Treatment Journey of COVID-19 Patients in Hospital Settings R. Moon, N. Rosenthal, H. Brown
521 [GO] 2021―Jun―04 IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States F. Sun, S. Jeyakumar, N. Smith
522 [GO] 2021―Jun―04 ML2 Supervised Machine Learning Predicts Mortality in COVID-19 Patients Using Electronic Health Records X. Marinaro, Z. Meng, X. Zhang, K. Lodaya, D.K. Hayashida, S. Munson, F. D'Souza
523 [GO] 2021―Jun―04 PIN1 Polypharmacy Among COVID-19 Patients: A Prisma-Based Systematic Review of Available Literature S. Iloanusi, O. Mgbere, E.J. Essien
524 [GO] 2021―Jun―04 PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System R. Ivos, I. Ribeiro-Vaz, J. Polónia, A. Silva
525 [GO] 2021―Jun―04 PRS30 COVID-19 RAPID Antigen Test False Positives and False Negatives Reported to the FDA Manufacturer and User Facility Device Experience Database M. Zettler, A. Gajra, B. Feinberg
526 [GO] 2021―Jun―04 PIH22 Efficacy Of Telephone-Based Educational Intervention On Knowledge Transfer Of COVID-19 Related Health Topics To Elderly Citizens In Hong Kong: A Pilot Study M.Y. Fung, Y.H. Lee, Y.T.A. Lee, M.L. Wong, J.T.S. Li, V. Lee
527 [GO] 2021―Jun―04 PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey N.J.R. Iloanusi, S. Iloanusi, O. Mgbere, A.I. Ajayi, E.J. Essien
528 [GO] 2021―Jun―04 PIN83 The COVID-19 Research Database: Building One of the Largest PRO Bono Real-World DATA Repositories A. Talwai, V. Wing, Y. Itzkovich, A. Galaznik, A. Chatterjee, R. Jain, J. LaBonte
529 [GO] 2021―Jun―04 PNS105 Patient Preferences and Feedback Regarding Daily Reporting of COVID-19 Symptoms Using Personal Smartphones for the Obvio-19 Study S. Dallabrida, H. Linke, P. Shah, M. Culbreth-Notaro
530 [GO] 2021―Jun―04 PIN54 Analysis of COVID-19 Treatment Drugs Availability in Ukraine O. Blavatska, I. Blavatskyi
531 [GO] 2021―Jun―04 PIN63 Choosing the Right COVID-19 Vaccine: A Multiple Stakeholder Multicriteria Decision Analysis For the Assessment of Available Vaccines in Latin America M.A. Espinoza, J. Guzman, J. Soto, G. Hernandez, D. Guarin, V. Boers Trilles, M. Martin De Bustamante
532 [GO] 2021―Jun―04 PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review O. Lau, N. Vadlamudi
533 [GO] 2021―Jun―04 PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults K. Rajagopalan, B. Mahadik
534 [GO] 2021―Jun―04 PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World C. Hildreth, K. Infante, N. Eslami, S. Garfield
535 [GO] 2021―Jun―04 PIN50 Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods S. Emerson, K. Johnston, A. Howarth, J. Schneider, M. Friesen, S. Szabo
536 [GO] 2021―Jun―04 PIN51 Role of Asymptomatic Carriers in the Transmission of COVID-19: A Review U. Abubakar, M. Hammad
537 [GO] 2021―Jun―04 PND48 Real World Data and COVID-19: Healthcare Impact in Emergency Care, Stroke Emergency Care and Stroke-Related Deaths in Chile L. Paez, R. Lenz, D. Paredes
538 [GO] 2021―Jun―04 PIN59 COVID-19: The Real-World Hospitalized Patient Experience L. Rasouliyan, V. Kumar, S. Long, M.B. Rao
539 [GO] 2021―Jun―04 PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19? K. Hernández, D. Paredes, R. Lenz
540 [GO] 2021―Jun―04 PMH18 Emotional Well-Being Among Pharmacy Students during the COVID Pandemic M. Zakeri, La Cruz A De, D. Wallace, S.D. Sadeghi, S.S. Sansgiry
541 [GO] 2021―Jun―04 MT1 Telehealth Utilization and Multiple Sclerosis Imaging Utilization in Four MS Centers during the COVID Pandemic: Real-world evidence from the MS-CQI improvement research collaborative. A. Chen, M. Molaei, A. Vaeth, K. Walsh, B. Oliver
542 [GO] 2021―Apr―19 Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic Jagpreet Chhatwal, Maarten J. Postma
543 [GO] 2021―Mar―11 Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands Niek Mouter, Marion Collewet, G. Ardine de Wit, Adrienne Rotteveel, Mattijs S. Lambooij, Roselinde Kessels
544 [GO] 2021―Mar―10 Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs Charles F. Manski, Aleksey Tetenov
545 [GO] 2021―Mar―09 Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States Anirban Basu, Varun J. Gandhay
546 [GO] 2021―Mar―06 Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study Benjamin Gravesteijn, Eline Krijkamp, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, Sophie Bruinsma, et al. (+7)
547 [GO] 2021―Feb―21 Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies Jidi Zhao, Huajie Jin, Xun Li, Jianguo Jia, Chao Zhang, Huijuan Zhao, et al. (+9)
548 [GO] 2021―Feb―21 How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Adrian Towse, Kalipso Chalkidou, Isobel Firth, Hannah Kettler, Rachel Silverman
549 [GO] 2020―Dec―11 PIN166 Health-Related Quality of Life (HRQOL) Outcomes and Potential Interventions in Patients Diagnosed with COVID-19. M. Sehgal, V. Pandey
550 [GO] 2020―Dec―11 PMD34 RAPID Medtech Innovation Briefings for COVID-19 R. Owens, Y. Wang, K. Carter
551 [GO] 2020―Dec―11 PIN170 The NOVEL Coronavirus Disease (COVID-19): Impacts on TESTS and Hospitalizations Performance in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
552 [GO] 2020―Dec―11 PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System S. Boeger, J. Petrovic, E. Busink, C. Apel, F. Kircelli, R. Pohlmeier
553 [GO] 2020―Dec―11 PIN167 Patient-Reported Outcomes to Capture the Signs, Symptoms and Impacts of COVID-19 and the IMPACT of the Pandemic on People with and without Infection M. Reaney, K. Heuer, J. Turnbull, J. Paty
554 [GO] 2020―Dec―11 CO2 WHEN Could a Second Wave of COVID-19 Appear in Germany and How Strong Will IT be? a Simulation Analysis S. Walzer
555 [GO] 2020―Dec―11 PIN120 The IMPACT of LONG-TERM Exposure to PM2.5, PM10 and NO2 Air Pollutants on the Age-Adjusted Mortality RATE of COVID-19 Based on the Example of Poland. A. Musiałek, A. Nosowicz
556 [GO] 2020―Dec―11 PIN122 Racial Disparity in COVID-19 Burden at the US Epicenter M. Bhattacharyya, R. Bhattacharyya, L.E. Miller, A.L. Miller, C. Stewart, S. Rojanasarot
557 [GO] 2020―Dec―11 PIN78 County-level differences in COVID-19 cases and fatalities in Germany A. Batscheider, J.A. Gossmann, R.A. Greiner, E. Shlaen, B. Antoni, D. Böckmann, et al. (+2)
558 [GO] 2020―Dec―11 PIN81 Within Country Regional Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in Hungary I. Boncz, A. Sebestyén, J. Betlehem, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
559 [GO] 2020―Dec―11 PIN112 Geographical Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in the European Union I. Boncz, E. Dora, A. Sebestyén, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
560 [GO] 2020―Dec―11 CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints Z. Kocaata, I. Simankova, T. Wilke
561 [GO] 2020―Dec―11 PNS245 Do Patient Preferences Change in a Pandemic? Exploring Italian Patient Reported Experience DATA during the COVID-19 Crisis K. Jamieson Gilmore, S. De Rosis, S. Nuti
562 [GO] 2020―Dec―11 PIN124 Analysis of Race and Ethnicity of COVID-19 Deaths in the United States C. Xavier, R. Rasu
563 [GO] 2020―Dec―11 PIN114 Estimation of Quality-Adjusted Life YEARS (QALY) Losses Associated with COVID-19 Deaths in Ukraine V. Serediuk, O. Piniazhko, O. Topachevskyi, T. Dumenko, L. Kovtun
564 [GO] 2020―Dec―11 PIN117 Identification of Patients with COVID-19 Infection Prior to the New COVID-19 Diagnostic Code - a Premier Database Analysis. C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+4)
565 [GO] 2020―Dec―11 PRS41 Understanding the Clinical Burden of ACUTE Respiratory Distress Syndrome (ARDS) in a COVID-19 Era - a Targeted Search and Epidemiological MODEL D. Tomaras, S. Harricharan, G. Tremblay, F. Anna
566 [GO] 2020―Dec―11 PCN224 An Italian Experience: How the COVID-19 Era HAS Modified the Radiological Activity in a Cancer Hospital A. Rossi, A. Prochowski Iamurri, C. Cerchione, N. Gentili, V. Danesi, M. Altini, et al. (+2)
567 [GO] 2020―Dec―11 PNS10 Research in the COVID-19 Era: Accelerating the Shift in the Research Paradigm from Traditional Towards Digital/Virtual Solutions D. Stein, M. Baltezegar
568 [GO] 2020―Dec―11 PIN178 Impact of Selected Comorbidities on Healthcare Resource Utilization Among Hospitalized Patients with COVID-19 in a US Population Z. Icten, I. Livingstone, J. Menzin
569 [GO] 2020―Dec―11 PMH16 Productivity, Depression, and Measures to Reduce Social IMPACT: The Economic IMPACT of COVID-19 in Brazil R. Andrade, D. Sansone, D. Farah, R. Garcia, G. Tannus, M. Fonseca
570 [GO] 2020―Dec―11 PIN90 Characteristics of Patients Died Due to Coronavirus Disease 2019 (COVID-19) in Hungary I. Boncz, J. Betlehem, E. Dora, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
571 [GO] 2020―Dec―11 PIN65 Socio-Economic Burden of COVID-19 in Russian Federation A. Kolbin, J. Gomon, Y. Balykina, D. Belousov, I. Ivanov
572 [GO] 2020―Dec―11 PIN75 Characteristics of Patients Diagnosed with COVID-19 in the US: A Descriptive Claims-Based Study from a National Perspective V. Divino, Y. Wang, C. Beggs, M. DeKoven
573 [GO] 2020―Dec―11 PIN87 Comparing Methodologies to Predict Incidence of COVID-19 in US Counties P. Coplan, S. Shah, A. Bhardwaj, A. Gurubaran, H. Dwarakanathan, G. Cafri, et al. (+5)
574 [GO] 2020―Dec―11 IN3 Impact of Government Measures on COVID-19 Incidence of Reported New Cases: An Analysis of 9 Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
575 [GO] 2020―Dec―11 PIN17 Healthcare Resource Utilization and Cost in Patients with Inpatient Mortality Due to COVID-19 Infection C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+5)
576 [GO] 2020―Dec―11 PIN82 The Influence of Social Distancing on COVID-19 Infections in the U.S. P. Coplan, G. Cafri, R. Khanna, A.S. Chitnis, B. Nandi, H. Dwarakanathan, et al. (+5)
577 [GO] 2020―Dec―11 PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States J. Chhatwal, O. Dalgic, P. Mueller, M. Adee, Y. Xiao, M.A. Ladd, et al. (+2)
578 [GO] 2020―Dec―11 PMH29 To Assess the Psychological IMPACT of COVID-19 Lockdown Among Healthy Individuals in India. S. P.B., K. Undela, R.K. Puvvada, B. Gupta, K. Manohar Rao, S. Palaksha
579 [GO] 2020―Dec―11 PIN139 The Cost-Effectiveness of COVID-19 Lockdowns in the United States R. Becker
580 [GO] 2020―Dec―11 PIN85 The Application of Global Influenza Pandemic Mortality Progression and Vaccine Production Strategies As Analogues for COVID-19 Management and Understanding. C. Fidler
581 [GO] 2020―Dec―11 CO3 Effectiveness of Government Measures to Reduce COVID-19 Mortality across 5 Different Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
582 [GO] 2020―Dec―11 PRS56 Cost-Effectiveness of Social Distancing to Reduce COVID-19 Mortality in the United States B. Bloudek, K. Migliaccio-Walle, P.J. Barrett, V. Nguyen, L. Bloudek
583 [GO] 2020―Dec―11 PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities M. Thomas, P. Craddy, G. Foxon
584 [GO] 2020―Dec―11 PCN3 IMPACT of COVID-19 on Immunotherapy Utilization in Metastatic NON-SMALL Cell LUNG Cancer P. Chopra, Y. Zhai, M. Myers
585 [GO] 2020―Dec―11 PCN293 Understanding Real-World Experiences and Impacts of COVID-19 on Patients with Breast Cancer: A Social MEDIA Listening Analysis S. Halhol, M. Raluy-Callado, M. Oguz, A. Booth
586 [GO] 2020―Dec―11 PNS263 Pandemics and Access to Care: Use of Real-World DATA to Examine the IMPACT of COVID-19 on Pharmacy Visits in JAPAN M. LoPresti, T. Seo, N. Sato
587 [GO] 2020―Dec―11 PMU84 IMPACT of COVID-19 on Physician Engagement and Life Science Companies' Digital and Operational Strategy N. Eslami, B. Harris, V. Parris, P. Sharan, S. Butler, K. Infante, et al. (+3)
588 [GO] 2020―Dec―11 PMD42 The IMPACT of COVID-19 on Telemedicine in Ophthalmology: A Literature Review D. O'Boyle, F. Carones, K. Darcy, B.S. Malyugin, R. Rejdak, L. Moccaldi, F. Vidal Aroca
589 [GO] 2020―Dec―11 PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies C. Teale, A. Roldan-Gomendio, S. Heinz, C. Sayadian, N. Jimenez
590 [GO] 2020―Dec―11 PIN123 How Much Will the COVID-19 Outbreak Have Cost the German Health Care System in the First Months Since the Outbreak? S. Walzer, L. Vollmer, S. Krenberger
591 [GO] 2020―Dec―11 PSU20 Attitude of Hungarian Adults Towards Emergency Plans before COVID-19 Outbreak in Hungary A. Kovács, A. Oláh, A. Pakai, E. Inhoff, G. Far, K. Wirthné-Gyergyák, et al. (+2)
592 [GO] 2020―Dec―11 PIN173 Studying Fake News on Twitter during the COVID-19 Pandemia in France A. Gedik, P. Foulquié, S. Renner, A. Mebarki, N. Texier, S. Schück
593 [GO] 2020―Dec―11 PIN66 A Scoping Review of the Literature on the Multifactorial Health-Economics Burden Caused By the COVID-19 Pandemic L. Chillotti, N. Largeron, G. Olivera
594 [GO] 2020―Dec―11 PIN126 Russian Mandatory Medical Insurance System Response to COVID-19 Pandemic M. Avxentyeva, V. Omelianovskiy, I. Zhelezniakova
595 [GO] 2020―Dec―11 PIN133 Medical Human Resource NEEDS of Chinese Health Professionals during the COVID-19 Pandemic. W. Hao, Z. Zhuang, W.K. Ming
596 [GO] 2020―Dec―11 PIN152 How Much Does a Life Cost? Lessons from the COVID-19 Pandemic A. Estévez-Carrillo, M. Cerezales, C. Crespo
597 [GO] 2020―Dec―11 PMD33 Estimating Societal Costs Associated with Vision Loss and Delayed Cataract Surgery: The Potential IMPACT of the COVID-19 Pandemic. D. O'Boyle, R. Busutil, L. Moccaldi
598 [GO] 2020―Dec―11 PMU7 Efficiency-Based Protocols for BEDS Evacuation during the COVID-19 Pandemic T. Nepomuceno, W.M.D.N. Silva, L.G.D.O. Silva
599 [GO] 2020―Dec―11 PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic K. Athanasakis, N. Nomikos, K. Souliotis, J. Kyriopoulos
600 [GO] 2020―Dec―11 PNS126 Simpli - a Capacity Simulator for Evaluating Measures to Reduce the Backlog of Hospital Services after the COVID-19 Pandemic C. Bandeiras, F. Oliveira, M. Mota, R. Moita Fidalgo, A. Oliveira, C. Franco, et al. (+4)
601 [GO] 2020―Dec―11 PUK21 The VALUE of a Sustainable and Resilient Technical Service Network and Its Importance in Times of the COVID-19 Pandemic C. Hornig, E. Busink, B. Lababidi, M. Luckau, T. Pohl, C. Mutz
602 [GO] 2020―Dec―11 SP3 Should I Choose Artificial Intelligence or Clinicians' Diagnosis? a Discrete Choice Experiment of Patients' Preference UNDER COVID-19 Pandemic in China T. Liu, W. Tsang, F. Huang, W.K. Ming
603 [GO] 2020―Dec―11 PIN49 Influenza Vaccination and Its IMPACT on the Availability Intensive Care Unit BEDS during the COVID-19 Pandemic in Colombia M. Pareja, S. Londono, M. Moreno
604 [GO] 2020―Dec―11 PCV78 Clinical Pharmacists Assistance during COVID-19 Pandemic in Patients with ACUTE Coronary Syndrome at a Tertiary Care Hospital in India. O. Gona, R. Madhan
605 [GO] 2020―Dec―11 PIN154 QALY Losses Attributable to COVID-19 Pandemic in Spain V. Hernando, M. Brosa
606 [GO] 2020―Dec―11 PMU85 IMPACT of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B. Halioua, J. Zetlaoui, A. Astruc, T. Lévy-Heidmann, D. Testa, A. Bombezin--Domino, L. Radoszycki
607 [GO] 2020―Dec―11 PMU109 IMPACT of the COVID-19 Pandemic on Patients with Immune-Mediated Inflammatory Diseases Taking a Biologic Therapy B. Halioua, J. Zetlaoui, A. Astruc, D. Testa, A. Bombezin--Domino, L. Radoszycki
608 [GO] 2020―Dec―11 PMH25 The IMPACT of the COVID-19 Pandemic on the Mental Health of US Adults: A CROSS-Sectional Study A. Morlock, R. Morlock, S. Holmstrom
609 [GO] 2020―Dec―11 PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis W. Padula, S. Malaviya, N. Reid, F. Chingcuanco, J. Ballreich, J. Tierce, G.C. Alexander
610 [GO] 2020―Dec―11 PCN216 An Innovative Organization MODEL to Face Risks Reduction Challenges in an Italian Cancer Center during the COVID-19 Pandemic: A Risk Reduction Estimation Study N. Gentili, A. Roncadori, I. Massa, C. Florescu, L. Bertoni, F. Galardi, et al. (+7)
611 [GO] 2020―Dec―11 PCN353 Oncology Treatments during COVID-19 Pandemic: IMPACT in a Health Care PLAN in Brazil J.P. Reis Neto, J. Busch
612 [GO] 2020―Dec―11 PNS116 Maintaining Routine Healthcare for Chronic Medical Conditions during the COVID-19 Pandemic: What WE CAN Learn from Australia Z.M. Thet Lwin, T.C. Higgins, K. Winn, K.H. Naing
613 [GO] 2020―Dec―11 PIN8 A MODEL for Estimation of Possible COVID-19 Patient Numbers in Turkey S. Öztopçu, E.B. Karahan, S. Ökçün, M. Kurnaz, G. Oğuzhan, Z. Caliskan, G. Kockaya
614 [GO] 2020―Dec―11 PDB45 Obesity: A Major Risk Factor for Adverse Outcomes Among Young COVID-19 Patients R. Kashambwa, Z. Drebert
615 [GO] 2020―Dec―11 PIN108 Using the Apriori Algorithm to Identify Risk Factors Associated with Survival and Mortality Among COVID-19 Patients A. Vashisht, C. Holy, S. Shah, N. Elangovanraaj, S. Johnston, P. Coplan
616 [GO] 2020―Dec―11 PIN171 A Real-World DATA Analysis of Mortality and Heart Arrhythmia Risk in Hospitalized COVID-19 Patients Treated with Hydroxychloroquine Z. Drebert, R. Kashambwa
617 [GO] 2020―Dec―11 PIN56 Cost of COVID-19 Patients Treatment in Turkey E.B. Karahan, S. Öztopçu, M. Kurnaz, S. Ökçün, Z. Caliskan, G. Oğuzhan, G. Kockaya
618 [GO] 2020―Dec―11 ML4 Application of Machine Learning Models to Evaluate COVID-19 Related ICU Utilization in a US Population Z. Icten, C. Chan, M. Munsell, J. Menzin
619 [GO] 2020―Dec―11 PNS198 Arogya Setu Mobile Application for COVID-19 Self-Assessment, Education and Participatory Disease Surveillance: Perception Among Medical and Technology University Students. J. Kochuparambil, A. Nidha
620 [GO] 2020―Dec―11 PUK20 Reimbursement Landscape in Europe As Hurdle or Accelerator of HOME Hemodialysis in COVID-19 Times E. Busink, J. Petrovic, D. Kendzia, S. Boeger, C. Apel
621 [GO] 2020―Dec―11 PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population M. Costa, P. Net, D. Proshenska, F. Bianic, F. Guelfucci
622 [GO] 2020―Dec―11 PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population P. Net, M. Costa, D. Proshenska, F. Bianic, F. Guelfucci
623 [GO] 2020―Dec―11 PNS206 Projecting the COVID-19 Weekly Deaths and Hospitalizations for Jefferson County, Kentucky P. Naiya
624 [GO] 2020―Dec―11 PIN3 Chloroquine and Hydroxychloroquine in COVID-19 with or without Azithromycin: A Systematic Review of in Vitro and Clinical Studies M. Jameleddine, N. Harzallah, H. Grati, M.C. Jebali, C. Hamouda
625 [GO] 2020―Dec―11 PMU82 Increasing Importance of Digital CME in a Post COVID-19 World N. Eslami, K. Infante, B. Harris, G. Erickson, C. Hoyvald, S. Garfield
626 [GO] 2020―Dec―11 PMU5 The Future of Market Access in a Post COVID-19 World - What Do WE Need to Do Differently? C. Teale, S. Morrison, R. Zeidman, R. Tolley, L. Flemingq
627 [GO] 2020―Dec―11 PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives K. Skaltsa, C. Ivanescu, M. Reaney
628 [GO] 2020―Dec―11 PIN110 Socioeconomic Factors Impacting COVID-19-Related Mortality in the United States E. Ridgway, N. Savant, G. Pauletti, J.A. Pieper, P. Juang
629 [GO] 2020―Dec―11 PMU59 The IMPACT of COVID-19: A Comparison of the Number of Regulatory and Health Technology Assessments between the First SIX Months of 2019 and 2020 M. Salvador, K.E. Young
630 [GO] 2020―Dec―11 PIN70 Knowledge Towards Universal Safety Precautions Among Healthcare Population in India during Initial Phase of COVID-19: A Web Based Survey J. Kochuparambil, A. Issac, S. George, N.K. Panicker
631 [GO] 2020―Dec―11 PRS81 Insights into the Coronavirus Disease Perceptions in Pakistan W. Ullah, H. Almansour, G. Victor, S. Hussain, A.J. Pienaar
632 [GO] 2020―Dec―11 CL4 Concerns, Quality of Life, Access to Care and Productivity of the General Population during the First 8 WEEKS of the Coronavirus Lockdown in Belgium and the Netherlands R. Michels, L.M.A. Goossens, R. Bruin, H. van Ballegooijen, M. Krol
633 [GO] 2020―Dec―11 PIN153 Lessons Learned from Economic Models of Influenza Vaccines and Applications to SARS-CoV-2 J. Benner, N. Adair, M. Friedman, J. Menzin, M. Sussman
634 [GO] 2020―Dec―11 PMU28 Multimodal Strategy to Control and Mitigate a Sars-COV-2 Epidemic Outbreak in the Emergency Service of Highly Complex Hospital in Santiago De Chile M. Galvez, J. Retamal, M. Chepo, K. Mondaca, C. Silva, N. Febré
635 [GO] 2020―Dec―11 PRS65 US Sars-COV-2 Geospatial Predictive Weather Mapping MODEL: Application of Machine Learned Bayesian Networks to Healthcare Decision Making J. Vanderpuye-Orgle, D. Erim, M. Maruszczak, S. Pandey, A. Shields, M. Keywood, et al. (+2)
636 [GO] 2020―Dec―11 PIN71 Comparison of Seasonality of Common Viral and Respiratory Diseases VS Emergence of Sars-COV-2 Infection D. Krishnan, C. Holy, S. Shah, N. Elangovanraaj, S. Gupta, P. Trivedi, et al. (+3)
637 [GO] 2020―Dec―11 PIN74 The Impact of Social Distancing on Sars-COV-2 Mortality: A US Analysis A. Gurubaran, C. Holy, S. Shah, B. Nandi, H. Dwarakanathan, A. Bhardwaj, et al. (+2)
638 [GO] 2020―Dec―11 PIN115 Understanding Sars-COV-2 Mortality: IMPACT of Population and Mobility Metrics S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
639 [GO] 2020―Dec―11 PIN111 Predicting the Decline in Sars-COV-2 New Infections: A Modelling Analysis of US Counties H. Dwarakanathan, O. Kakade, A. Bhardwaj, C. Holy, A. Gurubaran, S. Shah, P. Coplan
640 [GO] 2020―Dec―11 PRS58 IMPACT of Sars-COV-2 on Provided Healthcare. Evidence from the Emergency Phase in Italy. R. Di Bidino, A. Cicchetti
641 [GO] 2020―Dec―11 CO4 An Evaluation of the Differences in Vaccine Approval and Procurement Processes between Healthcare Systems during a Pandemic A. Robert, J. Farrington, L. Longworth
642 [GO] 2020―Dec―11 PIN145 Online- Education in Times of Pandemic a Strategy That Allows Change in Times of Crisis, an Example in Chile. N. Febré, V. Nasabun Flores, M.V. Badilla, S. Contreras, T. Pavlov, L.R. Diaz-Diaz, P. Ivanovic
643 [GO] 2020―Dec―11 PR3 Patient-Reported Outcome Measures to Prioritize Surgical Lists during Pandemic Events S. De Rosis, D.A. Lungu, F. Pennucci, S. Nuti
644 [GO] 2020―Dec―11 PCV81 Virtual Anticoagulation Clinic Care a Telehealth MODEL to Deliver Continuity of Anticoagulation Care during the COVID 19 Pandemic: Insights from Southern India O. Gona, S.K. S, R. Madhan
645 [GO] 2020―Dec―10 Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis Amir Shlomai, Ari Leshno, Ella H. Sklan, Moshe Leshno
646 [GO] 2020―Oct―13 The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19) C. Daniel Mullins, Michael F. Drummond
647 [GO] 2020―Oct―05 Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group Joy Leahy, Conor Hickey, David McConnell, Owen Cassidy, Lea Trela-Larsen, Michael Barry, et al. (+2)
648 [GO] 2020―Sep―06 Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations Dalia M Dawoud, Khaled Y Soliman
649 [GO] 2020―Sep―04 Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study Shelby Reed, Juan Marcos Gonzalez, F. Reed Johnson
650 [GO] 2020―Aug―27 Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the UK Darshan Zala, Iris Mosweu, Simone Critchlow, Renee Romeo, Paul McCrone
651 [GO] 2020―Jul―27 Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China Siyu Ma, David D. Kim, Joshua T. Cohen, Peter J. Neumann
652 [GO] 2020―May―21 The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable Steven Forsythe, Joshua Cohen, Peter Neumann, Stefano M. Bertozzi, Anthony Kinghorn
 [1] 

652 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.029 sec